Assessment of the Wilms' Tumor Gene (WT1) Expression in High-Risk Neuroblastoma (NB) Patients WHO Underwent Autologous Hematopoietic Stem Cell Transplantation (HSCT) (Englisch)
- Neue Suche nach: Khan, S.
- Neue Suche nach: Olszewski, M.
- Neue Suche nach: Kletzel, M.
- Neue Suche nach: Khan, S.
- Neue Suche nach: Olszewski, M.
- Neue Suche nach: Kletzel, M.
In:
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
;
20
, 2
;
S114
;
2014
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Assessment of the Wilms' Tumor Gene (WT1) Expression in High-Risk Neuroblastoma (NB) Patients WHO Underwent Autologous Hematopoietic Stem Cell Transplantation (HSCT)
-
Beteiligte:
-
Erschienen in:BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION ; 20, 2 ; S114
-
Verlag:
- Neue Suche nach: Elsevier Science B. V. Amsterdam
-
Erscheinungsdatum:01.01.2014
-
Format / Umfang:S114
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 617.4
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 617.4 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 20, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 145
-
Is Timing Everything?Rizzieri, D. et al. | 2014
- 146
-
Steroid-Refractory Acute Graft-versus-Host Disease: Is There an Effective Therapy?Antin, J. H. et al. | 2014
- 149
-
Blood and Marrow Transplant Clinical Trials Network: Progress since the State of the Science Symposium 2007Ferrara, J. L. et al. | 2014
- 154
-
Back to the Future! The Evolving Role of Maintenance Therapy after Hematopoietic Stem Cell TransplantationHourigan, C. S. / McCarthy, P. / de Lima, M. et al. | 2014
- 164
-
A Review of Cellular Therapies for Chronic Lymphocytic LeukemiaTomblyn, M. R. et al. | 2014
- 168
-
Immune-Modulating Drugs and Hypomethylating Agents to Prevent or Treat Relapse after Allogeneic Stem Cell TransplantationKröger, N. / Stübig, T. / Atanackovic, D. et al. | 2014
- 173
-
Prevention of Graft-versus-Host Disease by Adoptive T Regulatory Therapy Is Associated with Active Repression of Peripheral Blood Toll-Like Receptor 5 mRNA ExpressionSawitzki, B. / Brunstein, C. / Meisel, C. / Schumann, J. / Vogt, K. / Appelt, C. / Curtsinger, J. M. / Verneris, M. R. / Miller, J. S. / Wagner, J. E. et al. | 2014
- 183
-
Mammalian Target of Rapamycin Inhibitors Permit Regulatory T Cell Reconstitution and Inhibit Experimental Chronic Graft-versus-Host DiseaseSugiyama, H. / Maeda, Y. / Nishimori, H. / Yamasuji, Y. / Matsuoka, K. i. / Fujii, N. / Kondo, E. / Shinagawa, K. / Tanaka, T. / Takeuchi, K. et al. | 2014
- 192
-
IL-12hi Rapamycin-Conditioned Dendritic Cells Mediate IFN-γ–Dependent Apoptosis of Alloreactive CD4+ T Cells In Vitro and Reduce Lethal Graft-Versus-Host DiseaseStenger, E. O. / Rosborough, B. R. / Mathews, L. R. / Ma, H. / Mapara, M. Y. / Thomson, A. W. / Turnquist, H. t. et al. | 2014
- 202
-
Effect of Postremission Therapy before Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia in First Complete RemissionWarlick, E. D. / Paulson, K. / Brazauskas, R. / Zhong, X. / Miller, A. M. / Camitta, B. M. / George, B. / Savani, B. N. / Ustun, C. / Marks, D. I. et al. | 2014
- 209
-
Repair of Impaired Pulmonary Function Is Possible in Very-Long-Term Allogeneic Stem Cell Transplantation SurvivorsJain, N. A. / Pophali, P. A. / Klotz, J. K. / Ito, S. / Koklanaris, E. / Chawla, K. / Hourigan, C. S. / Gormley, N. / Savani, B. N. / Barrett, A. J. et al. | 2014
- 214
-
Umbilical Cord Blood as an Alternative Source of Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Epstein-Barr Virus–Associated T or Natural Killer Cell Lymphoproliferative DiseasesSawada, A. / Inoue, M. / Koyama-Sato, M. / Kondo, O. / Yamada, K. / Shimizu, M. / Isaka, K. / Kimoto, T. / Kikuchi, H. / Tokimasa, S. et al. | 2014
- 222
-
Prediction of Poor Mobilization of Autologous CD34+ Cells with Growth Factor in Multiple Myeloma Patients: Implications for Risk-StratificationCosta, L. J. / Nista, E. J. / Buadi, F. K. / Lacy, M. Q. / Dispenzieri, A. / Kramer, C. P. / Edwards, K. H. / Kang, Y. / Gertz, M. A. / Stuart, R. K. et al. | 2014
- 229
-
Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric PatientsKurtzberg, J. / Prockop, S. / Teira, P. / Bittencourt, H. / Lewis, V. / Chan, K. W. / Horn, B. / Yu, L. / Talano, J. A. / Nemecek, E. et al. | 2014
- 236
-
Mesenchymal Stem Cells versus Mesenchymal Stem Cells Combined with Cord Blood for Engraftment Failure after Autologous Hematopoietic Stem Cell Transplantation: A Pilot Prospective, Open-Label, Randomized TrialXiong, Y. Y. / Fan, Q. / Huang, F. / Zhang, Y. / Wang, Y. / Chen, X. Y. / Fan, Z. P. / Zhou, H. S. / Xiao, Y. / Xu, X. J. et al. | 2014
- 243
-
Low-Dose Serotherapy Improves Early Immune Reconstitution after Cord Blood Transplantation for Primary ImmunodeficienciesLane, J. P. / Evans, P. T. / Nademi, Z. / Barge, D. / Jackson, A. / Hambleton, S. / Flood, T. J. / Cant, A. J. / Abinun, M. / Slatter, M. A. et al. | 2014
- 250
-
Patient, Virus, and Treatment-Related Risk Factors in Pediatric Adenovirus Infection after Stem Cell Transplantation: Results of a Routine Monitoring ProgramMynarek, M. / Ganzenmueller, T. / Mueller-Heine, A. / Mielke, C. / Gonnermann, A. / Beier, R. / Sauer, M. / Eiz-Vesper, B. / Kohstall, U. / Sykora, K. W. et al. | 2014
- 257
-
Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab from HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients with Hematologic MalignanciesKanda, J. / Long, G. D. / Gasparetto, C. / Horwitz, M. E. / Sullivan, K. M. / Chute, J. P. / Morris, A. / Shafique, M. / Li, Z. / Chao, N. J. et al. | 2014
- 264
-
Analysis of Donor and Recipient ABO Incompatibility and Antibody-Associated Complications after Allogeneic Stem Cell Transplantation with Reduced-Intensity ConditioningWatz, E. / Remberger, M. / Ringden, O. / Lundahl, J. / Ljungman, P. / Mattsson, J. / Wikman, A. / Uhlin, M. et al. | 2014
- 272
-
Autoimmune Hematological Diseases after Allogeneic Hematopoietic Stem Cell Transplantation in Children: An Italian Multicenter ExperienceFaraci, M. / Zecca, M. / Pillon, M. / Rovelli, A. / Menconi, M. C. / Ripaldi, M. / Fagioli, F. / Rabusin, M. / Ziino, O. / Lanino, E. et al. | 2014
- 279
-
Allogeneic Stem Cell Transplantation for Myelofibrosis with Leukemic Transformation: A Study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow TransplantationAlchalby, H. / Zabelina, T. / Stübig, T. / van Biezen, A. / Bornhäuser, M. / Di Bartolomeo, P. / Beelen, D. / Cahn, J. Y. / Dreger, P. / Schroyens, W. et al. | 2014
- 282
-
Risk of Seizures in Children Receiving Busulphan-Containing Regimens for Stem Cell TransplantationCaselli, D. s. / Rosati, A. / Faraci, M. / Podda, M. / Ripaldi, M. / Longoni, D. / Cesaro, S. / Lo Nigro, L. / Paolicchi, O. / Maximova, N. et al. | 2014
- 285
-
Live Attenuated Varicella-Zoster Vaccine in Hematopoietic Stem Cell Transplantation RecipientsIssa, N. C. / Marty, F. M. / Leblebjian, H. / Galar, A. / Shea, M. M. / Antin, J. H. / Soiffer, R. J. / Baden, L. R. et al. | 2014
- 288
-
Severe Mucositis and Clostridium difficile Infection in Adult Autologous Stem Cell Recipients: Another Question of the Chicken or the Egg?Apewokin, S. / Wontumi, G. M. / Kumar, N. S. / Matin, A. / Grazziutti, M. et al. | 2014
- 289
-
2014 BMT TANDEM MEETINGS WILL BE FEB. 26-MAR. 2 NEAR DALLAS| 2014
- 290
-
Erratum| 2014
- A7
-
Table of Contents| 2014
- S2
-
Reprint of: Re-Examining the Role of High-Dose Chemotherapy in the Treatment of Light Chain AmyloidosisDevine, S. M. et al. | 2014
- S8
-
Reprint of: Back to the Future! The Evolving Role of Maintenance Therapy after Hematopoietic Stem Cell TransplantationHourigan, C. S. / McCarthy, P. / de Lima, M. et al. | 2014
- S18
-
Reprint of: A Review of Cellular Therapies for Chronic Lymphocytic LeukemiaTomblyn, M. R. et al. | 2014
- S22
-
Identification of Intestinal Commensal Bacteria Protective Against GVHD in Mice and HumansJenq, R. / van den Brink, M. R. et al. | 2014
- S23
-
ATG16L1 Prevents Lethal T-Cell Alloreactivity Mediated By Dendritic CellsShono, Y. / Hubbard-Lucey, V. / Maurer, K. / Dickinson, A. M. / Holler, E. / Cadwell, K. H. / van den Brink, M. R. et al. | 2014
- S24
-
Retrospective Study of 240 Patients with Severe Combined Immunodeficiency Transplanted from 2000-2009: A Report from the Primary Immune Deficiency Treatment Consortium of North AmericaPai, S. Y. / Logan, B. R. / Griffith, L. M. / Buckley, R. H. / Parrott, R. E. / Dvorak, C. C. / Kapoor, N. / Hanson, I. C. / Filipovich, A. / Jyonouchi, S. et al. | 2014
- S25
-
HLA-Mismatch Is Associated with Worse Outcomes after Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation: A Cibmtr AnalysisPidala, J. / Lee, S. J. / Spellman, S. R. / Wang, H. / Ahn, K. W. / Aljurf, M. D. / Askar, M. / Dehn, J. / Fernandez Viña, M. A. / Gratwohl, A. et al. | 2014
- S27
-
Iron Overload in Allogeneic Stem Cell Transplantation Outcome: A Meta-AnalysisArmand, P. / Kim, H. T. / Virtanen, J. / Itälä-Remes, M. / Majhail, N. S. / Burns, L. J. / Defor, T. / Trottier, B. / Platzbecker, U. / Antin, J. H. et al. | 2014
- S28
-
Less Acute Graft-Versus-Host Disease with Higher Mycophenolate Dose inBejanyan, N. / Rogosheske, J. / Defor, T. / Esbaum, K. / Arora, M. / MacMillan, M. L. / Wagner, J. E. / Weisdorf, D. / Jacobson, P. / Brunstein, C. G. et al. | 2014
- S29
-
T-Cell Replete Peripheral Blood Stem Cell Transplantation after Non-Myeloablative Conditioning with Post-Transplant High Dose Cyclophosphamide Is Safe and Is Associated with Acceptable OutcomesBhamidipati, P. K. / DiPersio, J. F. / Stockerl-Goldstein, K. / Uy, G. L. / Westervelt, P. / Gao, F. / Vij, R. / Schroeder, M. A. / Abboud, C. / Pusic, I. et al. | 2014
- S30
-
Higher Total Nucleated Cell Dose, but Not CD3+, 4+, 8+, or 34+ Cell Dose, Is Associated with Better Overall and Progression-Free Survival after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation (AlloPBHCT) with TBI-Based Conditioning RegimensBurns, M. / Singh, A. / Zhang, Y. / Chen, G. L. / Liu, H. / Ross, M. / McCarthy, P. L. / Hahn, T. et al. | 2014
- S31
-
Sequence of Cyclophosphamide (Cy) and Total Body Irradiation (TBI) Prior to Hematopoietic Cell Transplant (HCT) for Patients with Acute Leukemia: Impact upon Complications and Patient OutcomeHolter-Chakrabarty, J. L. / Zhang, M. J. / Zhu, X. / Akpek, G. r. / Aljurf, M. D. / Artz, A. S. / Baron, F. d. / Borden, A. M. / Bredeson, C. N. / Dvorak, C. C. et al. | 2014
- S32
-
Variations in the Use of a Race/Ethnic Matched Donor or Cord Blood Unit in Allogeneic TransplantsKempenich, J. / Buck, K. / Hermanson, J. / Dehn, J. et al. | 2014
- S33
-
Donor Telomere Length Predicts Recipient Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Bone Marrow Failure SyndromesGadalla, S. / Wang, T. / Haagenson, M. / Spellman, S. R. / Lee, S. J. / Williams, K. M. / Wong, J. Y. / De Vivo, I. / Savage, S. A. et al. | 2014
- S34
-
Detection of Relapse after Hematopoietic Stem Cell Transplantation in Childhood By Monitoring of Minimal Residual Disease and ChimerismGruhn, B. / Sanft, J. / Wolff, I. / Beck, J. F. et al. | 2014
- S35
-
Value of a Consensus Panel to Adjudicate Cause-Specific Mortality after Unrelated Donor Allogeneic Hematopoietic Cell Transplantation (URD-HCT) for Use As the Primary Endpoint in a Genome-Wide Association Study (GWAS)Hahn, T. / Sucheston-Campbell, L. / Preus, L. / Onel, K. / Zhu, X. / Liu, S. / Yan, L. / Tritchler, D. / Pasquini, M. C. / McCarthy, P. L. et al. | 2014
- S38
-
The Australian Experience with Relapsed Acute Myeloid Leukaemia Post Allogeneic Haematopoietic Stem Cell Transplantation Yields a Simple Prognostic Index for Survival after RelapseMing Lim, A. B. / Curley, C. / Fong, C. Y. / Bilmon, I. / Beligaswatte, A. / Purtill, D. / Getta, B. / Johnston, A. M. / Armytage, T. / Collins, M. et al. | 2014
- S39
-
Geriatric Assessment (GA) to Predict Survival in Older Allogeneic Hematopoietic Cell Transplantation (HCT) RecipientsMuffly, L. / Kocherginsky, M. / Stock, W. / Chu, Q. / Bishop, M. R. / Godley, L. / Kline, J. / Liu, H. / Odenike, O. / Larson, R. et al. | 2014
- S40
-
Haploidentical Transplantation for Advanced Hematologic Malignancies Using Melphalan-Based Conditioning – Mature Results from a Single CenterPingali, S. R. / Milton, D. / di Stasi, A. / Patel, R. D. / Kebriaei, P. / Popat, U. R. / Alousi, A. M. / Anderlini, P. / Qazilbash, M. H. / Hosing, C. et al. | 2014
- S41
-
Related PBSC Donors Age >60 Have High Rates of Baseline and Donation-Related Pain and Slow Recovery: First Report from the Related Donor Safety Study (RDSafe)Pulsipher, M. A. / Chitphakdithai, P. / Logan, B. R. / Switzer, G. E. / Tomblyn, M. R. / Rizzo, J. D. / Anderlini, P. / Leitman, S. F. / Varni, J. W. / Hays, A. et al. | 2014
- S42
-
Sargramostim (GM-CSF) Combined with IV Plerixafor to Mobilize Peripheral Blood Stem Cells (PBSC) from Normal HLA-Matched Allogeneic Sibling DonorsSchroeder, M. A. / Merida, S. / Schwab, D. / Rettig, M. P. / Meier, S. / Lopez, S. / Trinkaus, K. / Uy, G. L. / Cashen, A. / Stockerl-Goldstein, K. et al. | 2014
- S45
-
Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation (AutoHCT)Lane, A. A. / Chen, Y. B. / Logan, B. R. / Akpek, G. r. / Zhu, X. / Lazarus, H. M. / Bredeson, C. N. / Olsson, R. / Saber, W. / Aljurf, M. D. et al. | 2014
- S46
-
Impact of Hepatitis B Core Antibody (HBcAb) Seropositivity on the Outcome of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Multiple MyelomaBiritxinaga, L. / Jauch, S. F. / Popat, U. R. / Shafi, M. A. / Shah, N. / Bashir, Q. / Dinh, Y. / Hosing, C. / Champlin, R. E. / Qazilbash, M. H. et al. | 2014
- S47
-
Long-Term Outcome of Patients with AL Amyloidosis Treated with High-Dose Melphalan and Stem Cell Transplantation: 19 Year Experience at a Single CenterSanchorawala, V. / Doros, G. / Quillen, K. / Sloan, J. M. / Shelton, A. C. / Brauneis, D. / Finn, K. T. / Seldin, D. C. et al. | 2014
- S49
-
Third Party Donor Derived EBV Specific T Cells for the Treatment of Refractory EBV-Related Post-Transplant LymphomasProckop, S. E. / Doubrovina, E. S. / Barker, J. N. / Baroudy, K. / Boulad, F. / Kernan, N. A. / Khalaf, R. / Kobos, R. / Papadopoulos, E. / Sauter, C. et al. | 2014
- S50
-
In Vivo T Regulatory Cell Kinetics Are Altered in a Pre-Clinical Model of Chronic Graft-Versus-Host DiseaseBuxbaum, N. P. / Farthing, D. E. / Treadwell, S. / Bare, C. / Kapoor, V. / Telford, W. / Gress, R. et al. | 2014
- S51
-
Early Th1 Immunity Decreases Acute Graft-Versus-Host Disease and Impairs Graft-Versus-Leukemia Effect after Allogeneic Hematopoietic Cell TransplantationEngelhardt, B. G. / Jung, D. K. / Savani, B. N. / Jagasia, M. H. / Kassim, A. A. / Sengsayadeth, S. / Yoder, S. / Rock, M. / Crowe, J. E. et al. | 2014
- S52
-
Higher Mycophenolic Acid (MPA) Trough Levels Result in Lower Day 100 Severe Acute Graft-Versus-Host Disease (aGVHD) without Increased Toxicity in Double-Unit Cord Blood Transplantation (CBT) RecipientsHarnicar, S. / Ponce, D. M. / Mathew, S. / Evans, K. / Zheng, J. / Devlin, S. / Pozotrigo, M. / Scaradavou, A. / Kernan, N. A. / Adel, N. G. et al. | 2014
- S53
-
IL-22 Administration Protects Intestinal Stem Cells from GvhdLindemans, C. / Mertelsmann, A. / Dudakov, J. A. / Velardi, E. / Hua, G. / O'Connor, M. / Kolesnick, R. / van den Brink, M. R. / Hanash, A. M. et al. | 2014
- S54
-
Sensitization to HY-Antigen in Female Donors Was Not Associated with the Post-Transplant HY-IgG Development Nor Clinical Outcomes in Sex-Mismatched TransplantationNakasone, H. / Sahaf, B. / Tian, L. / Wang, T. / Haagenson, M. / Popli, R. / Lee, J. / Schoenrock, K. / Perloff, S. / Joshi, P. et al. | 2014
- S55
-
The Role of Gut Microbiota in the Development of Intestinal GVHDSimms-Waldrip, T. / Meir, M. / Fan, D. / Coughlin, L. / Savani, M. / Watt, T. / Aquino, V. / Koh, A. Y. et al. | 2014
- S57
-
Late Onset Colitis after Cord Blood Transplantation Is Consistent with Graft Versus Host Disease: Results of a Blinded Histopathological ReviewMilano, F. / Shulman, H. / Guthrie, K. A. / Riffkin, I. / McDonald, G. B. / Delaney, C. et al. | 2014
- S58
-
High Disease-Free Survival and Enhanced Protection Against Relapse after Double-Unit Cord Blood Transplantation (DCB-T) When Compared to Unrelated Donor Transplantation (URD-T) in Patients with Acute Leukemia, MDS and CMLPonce, D. M. / Devlin, S. / Lubin, M. / Maloy, M. / Castro-Malaspina, H. / Goldberg, J. D. / Jakubowski, A. A. / Papadopoulos, E. / Perales, M. A. / Sauter, C. et al. | 2014
- S59
-
Analysis of 402 Cord Blood Units to Assess Factors Influencing Infused Viable CD34+ Cell Dose: The Critical Determinant of EngraftmentPurtill, D. / Smith, K. / Meagher, R. / Lubin, M. / Scaradavou, A. / Stevens, C. / Barker, J. N. et al. | 2014
- S60
-
Immune Reconstitution after Autologous Stem Cell Transplantation for Multiple MyelomaChung, D. J. / Pronschinske, K. B. / Shyer, J. A. / Wu, V. / Hassoun, H. / Landau, H. / Lendvai, N. / Lesokhin, A. M. / Koehne, G. / Giralt, S. A. et al. | 2014
- S62
-
A 2-Step Approach to Haploidentical Versus Matched Related Hematopoietic Stem Cell Transplantation (HSCT): Equivalent Early Immune Reconstitution with Comparable OutcomesGaballa, S. / Carabasi, M. / Filicko, J. / Alpdogan, O. / Wagner, J. L. / Rosado, S. / Rudolph, S. / Kasner, M. / Martinez, U. / Weiss, M. et al. | 2014
- S63
-
Coping Strategies Modify the Risk of Depression Associated with Chronic Graft-Versus-Host Disease SeverityBarata, A. / Sutton, S. / Small, B. / Jacobsen, P. / Jim, H. et al. | 2014
- S65
-
Comprehensive Geriatric Assessment Identifies Significant Functional Impairments in Older Hematopoietic Cell Transplant RecipientsOlin, R. L. / Andreadis, C. / Martin, T. G. / Wolf, J. L. / Kaplan, L. D. / Ai, W. / Venstrom, J. M. / Logan, A. C. / Smith, C. C. / Gaensler, K. M. et al. | 2014
- S66
-
Comorbidity, History of Alcohol Disorders, and LDH Predict Non-Relapse Mortality (NRM) Among Recipients of Autologous Hematopoietic Cell Transplantation (HCT) for LymphomaVaughn, J. E. / Storer, B. E. / Chauncey, T. / Gopal, A. K. / Holmberg, L. / Bensinger, W. / Maloney, D. G. / Press, O. W. / Storb, R. F. / Sorror, M. L. et al. | 2014
- S67
-
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients with Central Nervous System InvolvementAoki, J. / Ishiyama, K. / Taniguchi, S. / Fukuda, T. / Ohashi, K. / Ogawa, H. / Morisima, Y. / Nagamura, T. / Atsuta, Y. / Sakamaki, H. et al. | 2014
- S68
-
Allotransplants for Acute Myeloid Leukemia: No Impact of Extra-Medullary Leukemia on OutcomesGoyal, S. D. / Uy, G. L. / Zhang, M. J. / Wang, H. L. / Devine, S. M. / de Lima, M. J. / Bunjes, D. W. / Weisdorf, D. et al. | 2014
- S69
-
Do Patients with High Risk or Relapsed Core Binding Factor Acute Myeloid Leukemia Benefit from Salvage Allogeneic Stem Cell Transplantation?Hobbs, G. / Kishtagari, A. / Hilden, P. / Barker, J. N. / Jakubowski, A. A. / Papadopoulos, E. / Devlin, S. / Boulad, F. / Kernan, N. / Kobos, R. et al. | 2014
- S70
-
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS) Following Intravenous Busulfan Plus Fludarabine Based Conditioning: Outcomes and Monocyte Chemo-Attractant Protein -1Khaled, Y. / Solh, M. / Fondaw, M. / Lamontagne, D. / Batista, A. / Chan-Fong, S. / Sullivan, J. / Matar, A. J. et al. | 2014
- S72
-
Radioimmunotherapy-Augmented Nonmyeloablative Allogeneic Transplantation Improves Outcomes for Refractory Indolent B-Cell Non-Hodgkin Lymphoma: Results of an Adjusted Cohort AnalysisCassaday, R. D. / Storer, B. E. / Sorror, M. L. / Sandmaier, B. M. / Guthrie, K. A. / Hedin, L. M. / Roden, J. E. / Rajendran, J. G. / Pagel, J. M. / Maloney, D. G. et al. | 2014
- S74
-
High-Throughput Sequencing of Antibody Genes Successfully Identifies Clonal Ig Rearrangements in Multiple Myeloma PatientsGarfall, A. L. / Luning Prak, E. T. / Meng, W. / Daber, R. / Zhang, B. / Hershberg, U. / Vogl, D. T. / Weiss, B. M. / Carroll, M. / Stadtmauer, E. A. et al. | 2014
- S75
-
Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Adults with Relapsed and Refractory Mantle Cell Lymphoma: A Single Center Retrospective Analysis in the Rituximab EraMussetti, A. / Devlin, S. / Castro-Malaspina, H. / Barker, J. N. / Giralt, S. A. / Sauter, C. / Perales, M. A. et al. | 2014
- S76
-
Exposure of Thymoglobulin Is Associated with Overall Survival in Children Receiving Allogeneic-Hematopoietic Cell Transplantation (HCT): Towards Individualized Dosing to Improve SurvivalAdmiraal, R. / Jol-van der Zijde, C. M. / van Kesteren, C. / van Tol, M. / Knibbe, C. A. / Bredius, R. / Boelens, J. J. et al. | 2014
- S78
-
Predictors of Long-Term Clinical Outcome in Hurler Syndrome Patients after Successful Hematopoietic Cell Transplantation: An International StudyAldenhoven, M. / Orchard, P. / Kurtzberg, J. / Wynn, R. / O'Meara, A. / Veys, P. / Fischer, A. / Valayannopoulos, V. / Neven, B. / Rovelli, A. et al. | 2014
- S79
-
Low Day 100 Transplant-Related Mortality and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogenic Stem Cell Transplantaiton in Children, Adolescents and Young Adults with Poor-Risk Acute LeukemiaChen, N. / Radhakrishnan, K. / Krajewski, J. / Ricci, A. / Geyer, M. / Harrison, L. / Ozkaynak, M. F. / Cheerva, A. / Talano, J. A. / Moore, T. B. et al. | 2014
- S80
-
Trend, Risk Factors and Outcome of Thrombotic Microangiopathy in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional ReviewKalpatthi, R. / Hall, M. / Woods, G. / Dalal, J. et al. | 2014
- S81
-
Allogenic Stem Cell Transplantation in Amegacaryocytosis : Results of a Retrospective Study in EBMT CentersDalle, J. H. / Fahd, M. et al. | 2014
- S82
-
Pre-Hematopoietic Cell Transplant (HCT) Disease Status and Early Post-HCT Bone Marrow (BM) Chimerism Remain Predictors of Leukemia Relapse in Children Who Receive Preemptive Post-HCT Immunomodulatory Therapy (IT)Horn, B. / Petrovic, A. / Wahlstrom, J. T. / Dvorak, C. C. / Kong, D. / Exposer-Spencer, J. / Cowan, M. J. et al. | 2014
- S84
-
Incidence of and Risk Factors for Cytomegalovirus (CMV), Epstein Barr Virus (EBV) and Adenovirus (ADV) Reactivation in Pediatric Recipients Post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHCT)Rustia, E. / Violago, L. / Jin, Z. / Bhatia, M. / Kung, A. / Foca, M. / George, D. / Garvin, J. / Satwani, P. et al. | 2014
- S85
-
Quantitative Monitoring of Minimal Residual Disease after Allogeneic Stem Cell Transplantation in Relapsed Childhood ALL Allows the Identification of Impending Relapse – Results of the ALL BFM SCT 2003 TrialBader, P. / Kreyenberg, H. / von Stackelberg, A. / Eckert, C. / Meisel, R. / Poetschger, U. / Stachel, D. / Schrappe, M. / Schrauder, A. / Schulz, A. et al. | 2014
- S86
-
Outcomes of Allogeneic Cord Blood Transplantation for Leukodystrophies; A Joint Study of Eurocord and "Inborn Errors WP-EBMT"Hol, J. / Ruggeri, A. / Rocha, V. G. / Michel, G. / Ayas, M. / O'Brien, T. / Krivan, G. / Bordon, V. / Schots, R. / Rovelli, A. et al. | 2014
- S87
-
Interplay of Recipient-Donor Matching for HLA, Race/Ethnicity and Gender on Long Term Outcomes in 365 Pediatric Recipients of Single 4/6 Matched Unrelated Cord Blood Transplantation (UCBT) after Myeloablative TherapyPrasad, V. K. / Mendizabal, A. / Page, K. / Parikh, S. / Wishnew, J. / Driscoll, T. A. / Martin, P. L. / Kurtzberg, J. et al. | 2014
- S88
-
Reduced Intensity Conditioning Regimen Combined with Single Unit Cord Blood Transplantation Is Effective and Safe for Children with Inherited Metabolic Disorders and Combined Immunodeficiency DiseasesLugt, M. V. / Chen, X. / Windreich, R. / Goyal, R. K. / Stenger, E. / Escolar, M. / Szabolcs, P. et al. | 2014
- S89
-
Allogeneic Stem Cell Transplant Offers Cure for Intractable Childhood EnteropathyWorth, A. J. / Nademi, Z. / Kammermeier, J. / Bunn, S. / Chiesa, R. / Cant, A. / Hambleton, S. / Shah, N. / Slatter, M. / Rao, K. et al. | 2014
- S91
-
Comparison of Infection Rates Among Acute Leukemia Patients in Remission Receiving Alternative Donor Hematopoietic Cell TransplantationBallen, K. K. / Chen, M. / Ahn, K. W. / Boeckh, M. J. / Auletta, J. J. / Szabolcs, P. / Tomblyn, M. R. et al. | 2014
- S93
-
Robust Vaccine Responses in Double-Unit Cord Blood Transplantation (CBT) Recipients Despite Lack of Transfer of Memory T and B CellsShune, L. / Purtill, D. / Lubin, M. / Lauer, E. / Giralt, S. A. / Papadopoulos, E. / Perales, M. A. / Ponce, D. M. / Kernan, N. / Scaradavou, A. et al. | 2014
- S94
-
Improved Cibmtr Data Capture through EMR Based PowerformCarraher, M. / Claxton, D. F. / Rybka, W. et al. | 2014
- S95
-
Transplant Information Patient System (TIPS): Development of a Web-Based Bone Marrow Transplant Workflow Tool, Providing Transplant Process Automation and EfficiencyYatawara, M. / Van Strien, P. / Dudley, K. / Huang, S. C. / Abess, L. / Guerrero, M. / Snoussi, L. / Caso, C. / Gharapetian, S. / Uy, L. et al. | 2014
- S96
-
Population Pharmacokinetic Modeling of Thymoglobulin in Children Receiving Allogeneic-Hematopoietic Cell Transplantation (HCT): Towards Individualized Dosing to Improve SurvivalAdmiraal, R. / van Kesteren, C. / Jol-van der Zijde, C. M. / van Tol, M. / Bartelink, I. / Bredius, R. / Boelens, J. J. / Knibbe, C. A. et al. | 2014
- S98
-
Efficacy of Late Hematopoietic Stem Cell Mobilization 35-40 Hours after Administration of PlerixaforBhushan, V. / Potter, J. / Sellers, K. / Badon, M. / Custodio, M. / Ingermann, D. / Kurre, J. / Lulo, A. / Samuel, D. et al. | 2014
- S99
-
Pharmacogenetic Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell TransplantsTeusink, A. / Vinks, A. / Zhang, K. / Fukuda, T. / Davies, S. M. / Lane, A. / Filipovich, A. / Mehta, P. A. et al. | 2014
- S101
-
A Pilot Study to Examine Sleep in Pediatric Brain Tumor Patients Hospitalized for High Dose Chemotherapy and Stem Cell RescueRickard, M. / Clifton, S. / Wallach, T. / Mandress, B. / Kjellin, M. et al. | 2014
- S102
-
Comparing the safety and efficacy of red blood cell transfusion dose in hematopoietic stem cell transplant patients: single versus double unit transfusionsEvans, R. / Avdic, A. / Smith, A. / Tucker, S. et al. | 2014
- S104
-
PK-Directed Intravenous Busulfan in Combination with High-Dose Melphalan and Bortezomib As Conditioning Regimen for Patients with Multiple MyelomaBarta, S. K. / Mazumder, A. / Carter, J. / Almanzar, L. / Elkind, R. / Battini, R. / Derman, O. / Kornblum, N. / Xue, X. / Verma, A. et al. | 2014
- S105
-
Chemosensitivity to Induction or High Dose Therapy, Pre/Post Transplant PET Negativity and Absence of Minimal Residual Disease within Mobilized Stem Cell Graft Predict Long Term Disease Free Survival in Multiple MyelomaBakanay, S. M. / Dalva, K. / Koksoy, E. B. / Civit, D. / Ayyildiz, E. / Ozcan, M. / Ilhan, O. / Beksac, M. et al. | 2014
- S106
-
25-Hydroxyvitamin D Concentrations and Overall Survival in Autologous Hematopoietic Stem Cell SubjectsClairmont, E. B. / Schoch, G. / Gopal, A. K. / McDonnell, P. et al. | 2014
- S108
-
Efficacy of Plerixafor with Same Day Administration and Mobilization: A Retrospective Chart Review of Patients with Multiple Myeloma and Lymphoma Undergoing Autologous Stem Cell TransplantEiseler, N. T. / Keyzner, A. / Roddy, R. / Donahue, L. / Bayer, R. L. et al. | 2014
- S109
-
Routine Radiographic Screening for Lymphoma before Autologous Stem Cell Transplantation (auto-SCT) Does Not Improve Relapse-Free Survival after Auto-SCTGanguly, S. / McRae, J. / He, J. / Divine, C. L. / Abhyankar, S. / Aljitawi, O. / McGuirk, J. et al. | 2014
- S110
-
Patterns of Referral for, and Utilization of, Blood and Marrow Transplantation (BMT) By RaceClay, A. / Peoples, B. / Ross, L. / Moysich, K. / Zhang, Y. / McCarthy, P. L. / Hahn, T. et al. | 2014
- S111
-
Mobilization for Autologous Stem Cell Transplantation in Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma: A Single Institution ExperienceHaverkos, B. M. / Geyer, S. / McBride, A. / Penza, S. / Devine, S. M. / Andritsos, L. A. / Jaglowski, S. et al. | 2014
- S112
-
BEAM Vs Melphalan Based Conditioning Therapy for Second Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)Veeraputhiran, M. / Jain, T. / Deol, A. / Uberti, J. / Kim, S. / Dyson, G. / Abidi, M. et al. | 2014
- S113
-
Autologous Stem Cell Mobilization in AL Amyloidosis with Plerixafor and G-CSF: Update of a Single Center ExperienceKaul, E. / Shah, G. L. / Chaulagain, C. / Comenzo, R. et al. | 2014
- S114
-
A Phase 1 Study of Targeted, Dose-Escalated Intravenous Busulfan in Combination with Etoposide As Preparative Therapy for Autologous Stem Cell Transplant in Acute Myeloid LeukemiaMannis, G. N. / Damon, L. E. / Ai, W. / Andreadis, C. / Gaensler, K. M. / Kaplan, L. D. / Logan, A. C. / Mahindra, A. / Olin, R. L. / Sayre, P. et al. | 2014
- S115
-
The Aethera Trial: An Ongoing Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at High Risk of Residual Hodgkin Lymphoma Following Autologous Stem Cell TransplantMoskowitz, C. / Nadamanee, A. / Masszi, T. / Agura, E. / Holowiecki, J. / Abidi, M. / Chen, A. / Stiff, P. / Gianni, A. / Carella, A. et al. | 2014
- S116
-
Routine Prophylaxis of Pneumocystis Jirovecii Pneumonia in Recipients of Autologous Hematopoietic Stem Cell TransplantationRaser, K. / McNulty, M. L. / Yanik, G. / Goldstein, S. C. / Magenau, J. / Pawarode, A. / Kitko, C. L. / Hanauer, D. / Levine, J. / Couriel, D. R. et al. | 2014
- S117
-
A Higher Number of CD34+ Cells Collected during Mobilization Is Independently Associated with Successful Engraftment in Autologous Stem Cell Transplant PatientsSharma, A. / Vasovic, L. / Xue, X. / Wang, D. / Braunschweig, I. / Barta, S. K. et al. | 2014
- S118
-
Target Value-Tailored Apheresis Can Improve Prediction of Product Hematopoietic Progenitor Cells Prior to Autologous TransplantationSheppard, D. / Tay, J. / Huebsch, L. / McDiarmid, S. A. / Martin, L. G. / Palmer, D. / Birch, P. / Xenocostas, A. / Hamelin, L. / Bredeson, C. N. et al. | 2014
- S119
-
Twenty Years of Autologous Stem Cell Transplantation in Diffuse Large B-Cell Lymphoma – a Single Center ExperienceBrito, M. D. / Manuel de Castro Campilho, F. / Ferreira, R. B. / Vaz, C. P. / Roncon, S. / Campos, A. et al. | 2014
- S120
-
Impacting VRE Rates on a Hematopoietic Stem Cell Transplant UnitBirdsey, K. / Cary, K. / Gullickson, C. / Thomas, D. et al. | 2014
- S121
-
Health Care Reform and Access to Hematopoietic Cell TransplantationGedan, A. C. et al. | 2014
- S122
-
Standardizing the Consent Form: A Quality ImprovementLiney, D. / Arsenault, T. / Alyea, E. P. et al. | 2014
- S123
-
Absolute Neutrophil Counts: Man Vs. MachineOdem, P. / Mann, J. et al. | 2014
- S124
-
Bridging the Gaps: Reducing Communication Barriers in the Pediatric Hematopietic Stem Cell Transplant ProgramRosati, C. / Haughton, C. et al. | 2014
- S125
-
Creation and Implementation of a Structured Outreach Program to Address Unmet Psychosocial, Financial and Emotional Needs of Related Stem Cell Donors Utilizing Data Analysis from a Qualitative Research StudySchoeppner, K. / Otterlei, L. / Leary, E. / Randall, J. / Defor, T. et al. | 2014
- S126
-
Standardization of IV Line Set-up to Improve Clinical OutcomesSteinke, T. et al. | 2014
- S128
-
Performance Validation of Revolution Centrifugal Force (RCF) for Plasma Depletion on Hematopoietic Progenitor Cell Apheresis Product Using Sorvall ST40R Centrifugechang-Fong, S. / Lamontagne, D. / Rathmann, K. / Batista, A. / Sullivan, J. / Solh, M. et al. | 2014
- S129
-
[18F]-Fhbg-PET/CT Imaging of CD34-TK75+ T Cells in Allogeneic HSCT Recipients after Donor Lymphocyte Infusion (IND#11917; Clinicaltrials.Gov Identifier: NCT00871702)Eissenberg, L. G. / Rettig, M. P. / Ritchey, J. K. / Fulton, R. / Dehdashti, F. / Piwnica-Worms, D. / DiPersio, J. F. et al. | 2014
- S130
-
T-Rapa6 and T-Rapa12 Cells Differentially Mediate Acute Gvhd after Low-Intensity Allogeneic HCTHalverson, D. / Rowley, S. / Hansen, B. / Schuver, B. B. / Mossoba, M. / Steinberg, S. / Hakim, F. / Kurlander, R. / Gea-Banacloche, J. / Sportes, C. et al. | 2014
- S131
-
Generation and Characterization of a Third Party GMP Grade Bank of CMV Specific T-Cells for Adoptive Immunotherapy of CMV Infections in Recipients of HSCT from Cord Blood or Seronegative DonorsHasan, A. N. / Doubrovina, E. S. / Koehne, G. / Prockop, S. E. / O'Reilly, R. et al. | 2014
- S132
-
T Cells Expressing Cars Directed Against HLA-0201 –Rmf WT-1 Peptide Complex Can Effectively Eradicate WT1+ A0201+ Tumor Cells in-VitroKuo, T. Y. / Hasan, A. N. / Zhao, Q. / Selvakumar, A. / Tassev, D. / Cheung, N. K. / O'Reilly, R. et al. | 2014
- S133
-
An Algorithm to Facilitate Successful and Cost Effective Hematopoietic Progenitor Cell (HPC) Harvests Based on Peripheral Blood HPC CD34 CountsParameswaran, R. / Cooper, L. / Guzman, A. / Roberts, L. / Lockhorst, R. / McCaul, K. et al. | 2014
- S134
-
Evaluating the Effector Function of Individual CD19-Specific T Cells to Assess the Therapeutic Impact of a Manufactured ProductSingh, H. / Liadi, I. / Romain, G. / Varadarajan, N. / Cooper, L. J. et al. | 2014
- S135
-
Familial Haploidentical (FHI) T-Cell Depleted (TCD) with T-Cell Addback Stem Cell Transplantation for Patients with High-Risk Sickle Cell Disease (SCD) (IND 14359)Talano, J. A. / Keever-Taylor, C. / Walters, M. / Shenoy, S. / Moore, T. B. / Parsons, S. K. / Abikoff, C. / Dozor, A. J. / Friedman, D. / Chitti, R. et al. | 2014
- S136
-
Automated Production of Clinical-Grade CMV-Specific T Cells to Implement Immunotherapy at the BedsideTewari, P. / Kumaresan, P. R. / Figliola, M. / Huls, H. / Longin, K. / Ruhnke, K. / Champlin, R. E. / Cooper, L. J. et al. | 2014
- S137
-
A Pilot Study of Unrelated Cord Blood (UCB) Transplantation and Unmatched Human Placental Derived Stem Cells (HPDSC) in Pediatric Malignant and Non-Malignant DiseaseAbikoff, C. / Shi, Q. / Giller, R. / Pulsipher, M. A. / Szabolcs, P. / Shenoy, S. / Moore, T. B. / Harrison, L. / Morris, E. / Militano, O. et al. | 2014
- S138
-
Double-Unit Cord Blood (CB) Transplantation Combined with Haplo-Identical CD34+ Cells Results in 100% CB Engraftment with Enhanced Myeloid RecoveryBarker, J. N. / Ponce, D. M. / Dahi, P. / Devlin, S. / Evans, K. / Lubin, M. / Meagher, R. / Castro-Malaspina, H. / Goldberg, J. D. / Jakubowski, A. A. et al. | 2014
- S139
-
Impact of HLA Disparity with High-Resolution HLA Typing at HLA-a, -B, -C, and –DRB1 on Engraftment after Reduced Intensity Cord Blood Transplantation in AdultsIshiwata, K. / Yamamoto, H. / Yuasa, M. / Kageyama, K. / Kaji, D. / Wada, S. / Ota, H. / Tsuji, M. / Yamamoto, G. / Asano-Mori, Y. et al. | 2014
- S140
-
HLA-DPB1 Mismatch and Chronic Graft-Versus-Host Disease Are Favorable Independent Risk Factor for Graft-Versus-Leukemia Effect in Leukemia Patients Transplanted Marrow from HLA-A, -B, -C, -DRB1 and -DQB1 Matched Unrelated DonorMorishima, Y. / Kashiwase, K. / Matsuo, K. / Azuma, F. / Onizuka, M. / Morishima, S. / Yabe, T. / Murata, M. / Toki, N. / Eto, T. et al. | 2014
- S141
-
A Universal Approach to Identify Permissible HLA-Mismatches in HSCT: Predicted Indirectly Recognizable HLA EpitopesThus, K. A. / Furst, D. / van Deutekom, H. / Calis, J. / Borst, E. / Kesmir, C. / Kuball, J. / Mytilineos, J. / Spierings, E. et al. | 2014
- S142
-
Comparative Analysis of T CELL Depleted Matched Vs Mismatched Unrelated DONOR Transplants in Patients with Hematologic MalignanciesWu, S. / Papadopoulos, E. / Maloy, M. / Hilden, P. / Devlin, S. / Barker, J. / Castro-Malaspina, H. / Goldberg, J. D. / Koehne, G. / Perales, M. A. et al. | 2014
- S144
-
Baseline Thymopoietic Function and Post-Transplant Immune Recovery after Adult Cord Blood TransplantationBenjamin, C. L. / Saliba, R. / Shpall, E. J. / de Lima, M. J. / St. John, L. / Szabolcs, P. / Champlin, R. E. / Komanduri, K. V. et al. | 2014
- S145
-
Maintenance of Naïve T Cells and a Diverse TCR Repertoire Are Critical for Reconstitution of EBV-Specific Immunity after Double Cord Blood TransplantationPolitikos, I. / Kim, H. T. / Nikiforow, S. / Nellore, A. / Li, L. / McDonough, S. M. / Soiffer, R. J. / Antin, J. H. / Ballen, K. K. / Cutler, C. S. et al. | 2014
- S146
-
Effect of Mobilization Method on Immune Reconstitution Post High Dose Chemotherapy and Autologous Stem Cell TransplantationSolh, M. / Smith, T. / Copik, A. / Khaled, Y. et al. | 2014
- S147
-
Symptom Burden, Quality of Life, and Employment Status after Stem Cell TransplantationHashmi, S. / Morrison, E. / Ehlers, S. L. / Bronars, C. / Patten, C. / Hogan, W. / Gastineau, D. et al. | 2014
- S148
-
Providing Care to a Hematopoietic CELL Transplant Recipient: Caregivers Describe Their Own Quality of LifeJim, H. / Quinn, G. / Barata, A. / Cases, M. / Cessna, J. / Flynn, A. / Gonzalez, B. / Gonzalez, L. / Gwede, C. / Koskan, A. et al. | 2014
- S149
-
Survival Advantage for Patients with AML and MDS Given Allogeneic Hematopoietic STEM CELL Transplantation Using Myeloablative Versus Reduced Intensity Conditioning (RIC) MAY Become Apparent 5-10 YEARS after TransplantationShimoni, A. / Shem-Tov, N. / Volchek, Y. / Danylesko, I. / Yerushalmi, R. / Nagler, A. et al. | 2014
- S151
-
Allogeneic Stem Cell Transplantation in High Risk ALL Patients: Influence of ALL SubtypesArnold, R. / Terwey, T. / Vuong, L. / Ostendorf, B. / Penack, O. / Massenkeil, G. / Hemmati, P. et al. | 2014
- S152
-
Clofarabine ± Fludarabine with IV Busulfan and Allogeneic Stem Cell Transplantation for Advanced Myeloid Leukemia (ML) and MDSChu, D. / Valdez, B. C. / Fox, P. S. / Thall, P. / Worth, L. / Popat, U. R. / Jones, R. B. / Shpall, E. J. / Hosing, C. / Alousi, A. M. et al. | 2014
- S153
-
The Role for Induction Chemotherapy and Allogeneic Stem Cell Transplant in Patients with Chronic Myelomonocytic Leukemia That Have Undergone Leukemic Transformation: A Single Center ExperienceGonsalves, W. I. / Gangat, N. / Gupta, V. / Al-Kali, A. / Hogan, W. / Hashmi, S. / Litzow, M. R. / Patnaik, M. et al. | 2014
- S154
-
Cord Blood Transplantation for Primary Refractory Acute Myeloid LeukemiaKageyama, K. / Yamamoto, H. / Kaji, D. / Ota, H. / Ishiwata, K. / Tsuji, M. / Yamamoto, G. / Asano-Mori, Y. / Uchida, N. / Izutsu, K. et al. | 2014
- S155
-
Preliminary Data from a Multi-Center Study of Clofarabine / Busulfan Conditioning for Acute Myeloid Leukemia Not in Remission at Allogeneic TransplantationMagenau, J. / Westervelt, P. / McGuirk, J. P. / Khaled, S. K. / Becker, P. S. / Jagasia, M. H. / Rowley, S. / Kim, D. / Frey, N. V. / Parameswaran, H. et al. | 2014
- S156
-
Allogeneic (Allo) Stem Cell Transplantation (SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1) with a Reduced Intensity Conditioning (RIC) of Fludarabine (Flu), 2 Day Busulfan (Bu2) and Horse ATG (hATG): The UMass ExperienceNath, R. / Cerny, J. / Ramanathan, M. / Raffel, G. / George, M. / Al-Mansour, Z. / Petrillo-Deluca, L. / Martin, T. / Desai, Z. / Bednarik, J. et al. | 2014
- S157
-
Extended Dose-Total Body Irradiation (18Gy) Followed By an Allogeneic Cell Transplantation for the Treatment of Refractory Acute Myeloid Leukemia: Early ResultsSabloff, M. / Altouri, S. / Atkins, H. / Allan, D. S. / Tay, J. / Le, M. / Hamelin, L. / Samant, R. / Sheppard, D. / Huebsch, L. B. et al. | 2014
- S158
-
High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation Early during the Course of Disease Appears to Improve Outcomes of Patients T Cell Non-Hodgkin Lymphoma: Results of a Single-Institution ExperienceAyala, E. / Tomblyn, M. R. / Kharfan-Dabaja, M. / Locke, F. / Nishihori, T. / Field, T. / Fernandez, H. / Pidala, J. / Betts, B. / Mishra, A. et al. | 2014
- S159
-
Phase 1 Trial of Carfilzomib + Melphalan (CarMel) Conditioning and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Relapsed Multiple Myeloma (MM)Costa, L. J. / Landau, H. / Venkata, J. K. / Kang, Y. / Koehne, G. / Chung, D. J. / Lendvai, N. / Bentz, T. / Giralt, S. A. et al. | 2014
- S160
-
M.DGramatzki, M. / Kellner, C. / Peipp, M. / Schub, N. / Humpe, A. / Staudinger, M. et al. | 2014
- S162
-
Results of 10-Year Single Center Experience with Pharmacokinetics Directed Intravenous Busulfan, Cyclophosphamide and Etoposide Preparative Regimen in Autologous Hematopoietic Stem Cell Transplantation for Intermediate and High Grade Non-Hodgkin LymphomaPatil, N. R. / Salzman, D. / Donnellan, W. / Vaughan, W. et al. | 2014
- S166
-
Prevalence and Impact of Poverty in Pediatric Allogeneic Hematopoetic Stem Cell TransplantBona, K. / Lehmann, L. E. / London, W. B. / Wolfe, J. et al. | 2014
- S167
-
Lymphopenia in Patients with Hemophagocytic Lymphohistiocytosis: Are B Cells Suppressed in These Patients?Chandra, S. / Filipovich, A. / Jordan, M. et al. | 2014
- S168
-
T-Cell-Replete Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Patients with X-Linked Adrenoleukodystrophy: An Immediate Choice for an Urgent SituationFernandes, J. / Bonfim, C. / Kerbauy, F. R. / Rodrigues, M. / de Moura Almeida, A. / Esteves, I. / Kutner, J. M. / Ribeiro, A. F. / Kok, F. / Hamerschlak, N. et al. | 2014
- S169
-
Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplants in Children: Single Center ExperienceHamidieh, A. A. / Behfar, M. / Jabalameli, N. / Jalali, A. / Aliabadi, L. S. / Hosseini, A. s. / Basirpanah, S. / Ghavamzadeh, A. et al. | 2014
- S171
-
Eosinophilia, Edema, and Nail Dystrophy: Harbingers of Severe Chronic Graft Versus Host Disease of the Skin in ChildrenHuang, J. T. / Lehmann, L. / Duncan, C. / Saavedra, A. et al. | 2014
- S172
-
Changes in Red Blood Cell Mean Corpuscular Volume after Pediatric HSCTQudeimat, A. / Wei, W. / Garrett-Mayer, E. / Lazarchick, J. / Hudspeth, M. et al. | 2014
- S175
-
Umbilical Cord Blood Transplantation Can be an Effective Therapy for Patients with Primary Immunodeficiency Diseases Who Lack an HLA-Matched Related DonorMartinez, C. / Shearer, W. / Orange, J. / Rosenblatt, H. / Leung, K. / Naik, S. / Gottschalk, S. / Allen, C. / Ahmed, N. / Sasa, G. et al. | 2014
- S176
-
Prevalence of Diseases and Conditions Amenable to Stem Cell Transplant or Infusion Among Families Storing Newborn Stem Cells at a Large Private Cord Blood BankMazonson, P. / Santas, C. / Harris, H. / Brown, H. / Mohr, A. / Stanley, L. / Colberg, K. et al. | 2014
- S177
-
The Contribution of Cardiac Hypertrophy on Transplant Outcome in Patients with HLH Undergoing BMTLehmann, L. E. / Nagy, A. et al. | 2014
- S178
-
Outcome after Stem Cell Transplant in Patients with Dyskeratosis CongenitaNaik, S. / Sasa, G. / Bertuch, A. / Martinez, C. / Omer, B. / Allen, C. / Ahmed, N. / Gottschalk, S. / Heslop, H. E. / Brenner, M. K. et al. | 2014
- S179
-
HLA Identical Siblings Are the Best Donors for Children with ALLPeters, C. / Schrauder, A. / Schrappe, M. / von Stackelberg, A. / Bader, P. / Ebell, W. / Lang, P. / Kremens, B. / Sykora, K. W. / Mueller, I. et al. | 2014
- S180
-
Bone Marrow Transplant for Children with CML Presenting in Blast Crisis in the Era of TKIsShulman, D. S. / Lehmann, L. E. / Margossian, S. et al. | 2014
- S181
-
A Single Center Experience of Haploidentical Stem Cell Transplants in Pediatric DiseasesTan, P. L. / Villegas, M. S. / Soh, T. G. / Law, P. / Yeoh, A. / Quah, T. C. et al. | 2014
- S182
-
Fludarabine, Busulfan and Melphalan Conditioning in Pediatric Myeloid Malignancies Undergoing Hematopoietic Stem Cell TransplantationVillegas, M. S. / Seo, W. L. / Chua, H. C. / Quah, T. C. / Yeoh, A. / Tan, P. L. et al. | 2014
- S184
-
Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk SarcomasHuang, X. / Greene, J. / Pao, J. / Mulvey, E. / Zhou, S. X. / Sachdev, D. / Yee, D. / Rader, C. / Albert, C. M. / Park, H. et al. | 2014
- S185
-
Xenotransplantation of Human Cord Blood Derived Unrestricted Somatic Stem Cells Rescue the Blistering Phenotype in a Murine Model of Recessive Dystrophic Epidermolysis BullosaLiao, Y. / Ivanova, L. / Surapaneni, B. / Yahr, A. / Cairo, M. S. et al. | 2014
- S187
-
Experience in a Public Cord Blood Bank Using a Segment-Based Aldehyde Dehydrogenase Assay As a Biomarker for Umbilical Cord Blood PotencyShoulars, K. / Troy, J. D. / Noldner, P. / Gentry, T. / Page, K. / Storms, R. / Balber, A. E. / Kurtzberg, J. et al. | 2014
- S188
-
Role of Early Initiation of Continuous Veno-Venous Hemofiltration (CVVH) for Management of Sinusoidal Obstructive Syndrome (SOS) Following Stem Cell Transplant (SCT)Raina, R. / Vogt, B. / Cunningham, R. / Cabral, L. / Abusin, G. / Auletta, J. J. / Cooke, K. R. / Abu-Arja, R. et al. | 2014
- S189
-
Continuous Intravenous Immunoglobulin and Platelet Infusion in Allogeneic Stem Cell Transplant Patients with Allo-Immune ThrombocytopeniaAncevski, K. / Cook, R. / Koth, S. / Fallon, M. et al. | 2014
- S190
-
Low Dose Defibrotide for Management of Hepatic Veno-Occlusive DiseaseBagal, B. / Choughale, A. / Khattry, N. N. et al. | 2014
- S191
-
Tolerability of Foscarnet As a Continuous Infusion for Treatment of Herpesvirus InfectionsBrown, J. W. / Chang, A. / Lee-Lam, F. y. / Tan, S. K. / Shashidhar, S. et al. | 2014
- S192
-
Levels of Immunoglobulin G in Patients Undergoing Stem Cell TransplantationEbeid, M. / Starnes, S. E. / McDonald, S. / Megason, G. et al. | 2014
- S193
-
Risk Factors for Infections in Recipients of Hematopoietic Cell Transplantation in Relation to Donor SourceFlagg, A. / Hanna, R. / Mossad, S. B. / Rybicki, L. / Hamilton, B. K. / Gerds, A. / Sobecks, R. / Duong, H. / Andresen, S. / Bolwell, B. et al. | 2014
- S194
-
Management of Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell TransplantationGurman, G. / Atilla, E. / Ozen, M. / Kubilay, P. / Yilmaz, G. / Gunduz, M. / Arslan, O. / Ozcan, M. / Demirer, T. / Akan, H. et al. | 2014
- S195
-
Differential Effect of Supersaturated Calcium Phosphate Rinse and Palifermin on Oral Mucositis Induced By Conditioning with Fludarabine, Busulfan and TBI or MelphalanHadid, T. / Sahovic, E. A. / Berteotti, G. / Lister, J. et al. | 2014
- S196
-
Significant Transplant-Related Mortality from Respiratory Virus Infections within the First 100 Days Post Hematopoietic Stem Cell TransplantationHutspardol, S. / Schechter-Finkelstein, T. / Ali, M. / Krueger, J. / Egeler, R. M. / Allen, U. / Richardson, S. / Gassas, A. et al. | 2014
- S197
-
Early Use of Inhaled Ribavirin Can Improve Outcomes in High Risk Hematopoietic Stem Cell Transplant and Leukemia Patients with RSV InfectionMihelic, R. / Morris, L. / Holland, H. K. / Bashey, A. / Zhang, X. / Solomon, S. R. et al. | 2014
- S198
-
Immunogenicity of a Lived-Attenuated Japanese Encephalitis Vaccine in Children after Hematopoietic Stem Cell TransplantationPakakasama, S. / Wattanatitan, S. / Techasaensiri, C. / Yoksan, S. / Sirireung, S. / Hongeng, S. et al. | 2014
- S199
-
The Effect of Communication Skills Training on Nurses' Confidence and Competence in Providing Psychosocial Support to Patients and FamiliesPenko, S. et al. | 2014
- S200
-
Effects of Calcineurin Inhibitors on Urinary Sodium Excretion Early after Allogenic Hematopoietic Stem Cell TransplantationSaburi, M. / Mori, T. / Kato, J. / Koda, Y. / Kohashi, S. / Okamoto, S. et al. | 2014
- S201
-
Antibiotic Prophylaxis Therapy for Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant (HSCT): A Tale of 2 CentersSchechter, T. / Gassas, A. / Klein, J. / Doyle, J. / Berger, A. / Ali, M. / Lu, P. / Domm, J. / Krueger, J. / Egeler, R. M. et al. | 2014
- S202
-
Retrospective Analysis of Oral Versus Intravenous Tacrolimus in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationSimondsen, K. / Mably, M. / Fischer, J. / Eckstein, L. / Gage, B. / Callander, N. et al. | 2014
- S204
-
A Prospective, Randomized Clinical Trial of Cryotherapy Vs. Supersaturated Calcium Phosphate Rinses Vs. Saline Rinses for the Prevention of Oral Mucositis in Patients with Multiple Myeloma (MM) Receiving High-Dose Melphalan (HDM) and AutotransplantationToro, J. J. / Schneider, D. / Alonzo, R. / Hasan, A. / Lee, S. / Gushiken, F. / Haile, D. J. / Freytes, C. O. et al. | 2014
- S205
-
Incidence and Outcomes of Bacteremia with Common Over-the-Counter Probiotic Organisms Among Hematopoietic Cell Transplant RecipientsWoodfield, M. / Boyle, N. / Stednick, Z. / Boeckh, M. J. / Pergam, S. A. et al. | 2014
- S206
-
Parametric Response Mapping as a Diagnostic Indicator of Bronchiolitis Obliterans SyndromeGalban, C. J. / Boes, J. L. / Bule, M. / Meyer, C. R. / Couriel, D. R. / Kitko, C. L. / Ponkowski, M. / Johnson, T. D. / Lama, V. / Kazerooni, E. A. et al. | 2014
- S207
-
Extending the Bridg Model with Hematopoietic Cell Transplant ConceptsPollack, J. / Schaper, K. / Renner, R. / Martinez, C. / Sorensen, S. / Milius, B. / O'Neill, C. / Jones, R. B. / Rizzo, J. D. et al. | 2014
- S208
-
Novel Electronic Data Capture Tool Is More Time Efficient for Adverse Event (AE) Capture and ReportingSpencer, H. E. / Graves, S. / Lankford, A. / Farrell, D. / Altherr, T. / Lee, C. G. / Beitinjaneh, A. / Volodin, L. / Camblos, A. K. / Kindwall-Keller, T. L. et al. | 2014
- S209
-
Smartphrases: Streamlining Electronic Documentation of Patient Data for CIBMTR Reporting and Clinical Research ComplianceSpencer, H. E. / Lankford, A. / Williams, P. G. / Craghead, T. / Lee, C. G. / Altherr, T. / Beitinjaneh, A. / Volodin, L. / Kindwall-Keller, T. L. et al. | 2014
- S211
-
Allogeneic Match Unrelated DONOR Trasplantation: First Experience in ColombiaAbello, V. / Villamizar, L. / Pedraza, E. / Esguerra, H. / Rosales, C. / Rosales, M. / Figueroa, J. / Cordoba, I. et al. | 2014
- S212
-
The Addition of Extracorporeal Photophoresis (ECP) to Tacrolimus and Methotrexate to Prevent Acute and Chronic Graft-Versus Host Disease (aGvHD, cGvHD) in Patients Undergoing a Myeloablative (MA) Hematopoietic Cell Transplant (HCT)Abhyankar, S. / Yankee, T. / Warhadpande, D. / Hirner, A. / Bunch, J. / Merkel, D. / Ganguly, S. / Aljitawi, O. / McGuirk, J. P. et al. | 2014
- S213
-
Safety and Efficacy of Haploidentical Stem Cell Transplantation for Advanced Chronic Myeloid LeukemiaAdekola, K. / di Stasi, A. / Ferro, R. / Ahmed, S. / de Lima, M. J. / Oran, B. / Andersson, B. S. / Quintas-Cardama, A. / Jabbour, E. / Kantarjian, H. et al. | 2014
- S215
-
What Happens Next? - Outcomes after Relapse Following Allogeneic Haematopoietic Stem Cell Transplant for Acute Leukemia in AdultsBrown, L. / Rowlings, P. et al. | 2014
- S216
-
The Impact of ABO Incompatibility in Allogeneic Stem Cell Transplant (ALLOSCT): A Retrospective Single Center's AnalysisCerny, J. / Ramanathan, M. / Raffel, G. / Fortier, N. / Shanahan, L. / Martin, T. / Petrillo-Deluca, L. / Bednarik, J. / Nath, R. et al. | 2014
- S217
-
Phase II Trial of Reduced Intensity Busulfan / Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with AML, MDS, and ALLChen, Y. B. / Li, S. / Del Rio, C. / Coughlin, E. / Ballen, K. K. / Cutler, C. S. / Dey, B. R. / Ho, V. T. / McAfee, S. L. / Spitzer, T. R. et al. | 2014
- S218
-
Early Human Herpesvirus Type 6 Reactivation in Umbilical Cord Blood Allogeneic Stem Cell TransplantationCirrone, F. / Ippoliti, C. / van Besien, K. et al. | 2014
- S219
-
Frequency and Impact of Allogeneic Hematopoetic Stem Cell Transplant and Preparative Regimen in Patients with High and Intermediate Risk AML at a Small CenterFarhan, S. / Neme, K. / Mikulandric, N. / Ruemenapp, K. / Trapp, M. A. / Szymanski, S. / Peres, E. / Janakiraman, N. et al. | 2014
- S220
-
Impact of Dysplasia on Outcome of Patients with Acute Myeloid Leukemia and Response to Allogeneic Hematopoetic Stem Cell TransplantFarhan, S. / Neme, K. / Mikulandric, N. / Ruemenapp, K. / Szymanski, S. / Trapp, M. A. / Peres, E. / Janakiraman, N. et al. | 2014
- S221
-
Pre-Transplant Azacitidine and Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes of One Hundred Fifty-Nine Patients up to Age Seventy-Five with Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)Field, T. / Perkins, J. / Hillgruber, R. / Nishihori, T. / Tomblyn, M. R. / Mishra, A. / Pidala, J. / Locke, F. / Perez, L. E. / Betts, B. et al. | 2014
- S222
-
Lower Incidence of CMV Reactivation Following Allogeneic Stem Cell Transplantation Despite a High Seroprevalence - a Single Centre ExperienceGeorge, B. / Devasia, A. / Mathews, V. / Lakshmi, K. / Viswabandya, A. / Abraham, A. / Ganapule, A. / Srivastava, A. et al. | 2014
- S223
-
Characteristics and Outcome of Cytomegalovirus (CMV) Infections in 95 Cord Blood Transplant (CBT) Recipients: The MD Anderson ExperienceGhantoji, S. S. / Goddu, S. / Sreenivasula, S. / Shah, D. P. / Oran, B. / Rezvani, K. / Rondon, G. / Shpall, E. J. / Chemaly, R. F. et al. | 2014
- S224
-
Fludarabine Metabolite Level on Day Zero Does Not Affect Outcomes of Hematopoietic Cell Transplantation in Patients with Normal Renal FunctionGriffiths, C. D. / Ng, E. S. / Kangarloo, B. / Williamson, T. S. / Booker, R. / Yue, P. / Duggan, P. R. / Savoie, M. L. / Brown, C. / Daly, A. et al. | 2014
- S225
-
Post-Transplant Lymphoproliferative Disorder Is Common after Reduced-Intensity ATG Conditioning and Haplo-Cord TransplantationSmith, S. / van Besien, K. / Gundeti, A. / Kline, J. / Liu, H. / Bishop, M. R. / Venkataraman, G. / Artz, A. S. et al. | 2014
- S226
-
Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)Hamilton, B. K. / Rybicki, L. / Gerds, A. / Hanna, R. / Sobecks, R. / Duong, H. / Starn, J. / Corbett, E. / Bolwell, B. / Majhail, N. S. et al. | 2014
- S227
-
Voriconazole Exposure and the Risk of Cutaneous Squamous Cell Carcinoma in Allogeneic Hematopoietic Stem Cell Transplant PatientsHashmi, S. / Wojenski, D. / Merten, J. / Wolf, R. / Bartoo, G. / Wilson, J. / El-azhary, R. / Dierkhising, R. / Patnaik, M. / Hogan, W. et al. | 2014
- S228
-
Hepatitis Due to Human Herpesvirus 6 after Hematopoietic Stem Cell TransplantationHill, J. A. / Zerr, D. / Sedlak, R. H. / Jerome, K. R. / Myerson, D. et al. | 2014
- S229
-
Prevalence of Chromosomally Integrated Human Herpesvirus 6 (HHV-6) Among Patients with HHV-6-Associated Post-Stem Cell Transplant Acute Limbic EncephalitisHill, J. A. / Zerr, D. / Sedlak, R. H. / Jerome, K. R. / Boeckh, M. J. et al. | 2014
- S230
-
Comparison of Fludarabine and Total Body Irradiation (FluTBI) to Fludarabine without TBI (Flu) Based Nonmyeloabltive Conditioning (NMA) Prior to Hematopoietic Cell Transplantation (HCT) for LymphomaHong, S. / Le Rademacher, J. / Carreras, J. / Kroll, T. M. / Klein, J. P. / Pasquini, M. C. et al. | 2014
- S231
-
A Novel Reduced Intensity Conditioning Regimen for Patients with High Risk Hematologic Malignancies Undergoing Conventional Allogeneic Stem Cell TransplantationHobbs, G. / Kaur, N. / Ponce, D. M. / Hilden, P. / Castro-Malaspina, H. / Giralt, S. A. / Goldberg, J. D. / Papadopoulos, E. / Jakubowski, A. A. / Sauter, C. S. et al. | 2014
- S233
-
Low Dose Thymoglobulin Result in Improved Outcomes after Allogeneic Unrelated Hematopoietic Stem Cell Transplantation (HCT) for Patients with Acute Myeloid Leukemia/ Myelodysplastic Syndrome Conditioned with Intravenous Busulfan and FludarabineMatar, A. J. / Fondaw, M. / Smith, T. / Balls, J. / Solh, M. / Khaled, Y. et al. | 2014
- S234
-
Addition Of Thiotepa To The Conditioning Regimen Significantly Improves Transplant Outcomes In Children Undergoing Cord Blood Transplantation For Non-Malignant Disease. Lurie Children's Hospital Of Chicago's ExperienceMerchant, M. / Duerst, R. E. / Rademaker, A. / Kletzel, M. et al. | 2014
- S235
-
Increased Transplant Related Mortality and Poor Donor Cell Chimerism in African American Children Undergoing Umbilical Cord Blood Transplantation. Institutional Experience at Lurie Children's Hospital of ChicagoMerchant, M. / Duerst, R. E. / Rademaker, A. / Kletzel, M. et al. | 2014
- S236
-
Allogeneic Transplantation for MDS/AML Patients with Germline GATA2 MutationsKochuparambil, S. / Jackson, A. / Litzow, M. R. / Khan, S. P. / Rodriguez, V. / Abraham, R. / Hogan, W. / Patnaik, M. et al. | 2014
- S238
-
Outcomes of Relapse of AML Post Allogeneic Transplantation in the Era of Hypomethylating Agents: An Analysis of 162 Allogeneic Transplants from a Single CenterLaPorte, J. / Zhang, X. / Hussain, Z. / Brown, S. / Sizemore, C. / Sanacore, M. / Mihelic, R. / Leech, M. / Morris, L. / Holland, H. K. et al. | 2014
- S239
-
Variable Success Rates of Haplo-Cord Transplants in High Risk Patients: A Minimum Serotherapy Exposure Is a Prerequisite for Sustainable EngraftingLindemans, C. / Boome, L. t. / Jol- van der Zijde, C. M. / Wensing, A. M. / Admiraal, R. / Bierings, M. / Kuball, J. / Boelens, J. J. et al. | 2014
- S240
-
Risk Factors for Recurrent Clostridium Difficile Infection in Allogeneic Hematopoietic Stem Cell Transplant RecipientsMani, S. / Rybicki, L. / Jagadeesh, D. / Mossad, S. B. et al. | 2014
- S243
-
Recipient T-Cell Repertoire Diversity after Double Umbilical Cord Transplantation Correlates with Non-Relapse Mortality and SurvivalNikiforow, S. / Kim, H. T. / McDonough, S. M. / Emerson, R. / Hamm, D. / Ballen, K. K. / Boussiotis, V. A. / Soiffer, R. J. / Antin, J. H. / Ritz, J. et al. | 2014
- S244
-
Co-Stimulatory Blockade Permits Transplantation of Human Hematopoitic Stem Cells and HLA Incompatible T Cells in NOD/SCID γ Null (NSG) MiceOh, A. / Mahmud, D. / Nicolini, B. / Bonetti, E. / Mahmud, N. / Patel, P. / Rondelli, D. et al. | 2014
- S247
-
Critical Care Unit Admission Of Hematopoietic Stem Cell Transplant Patients In An University Hospital In ChileRamirez, P. A. / Escobar, K. / Rojas, P. / Bertin, P. / Nervi, B. / Jara, V. / Ocqueteau, M. / Garcia, M. J. / Sarmiento, M. / Ernst, D. et al. | 2014
- S249
-
Subsequent Malignant Neoplasms after Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning and Outpatient ConductionZamora-Ortiz, G. / Velazquez-Sanchez-de-Cima, S. / Ponce-de-León, S. / Gutierrez-Aguirre, C. H. / Ruiz-Delgado, G. J. / Gomez-Almaguer, D. / Ruiz-Arguelles, G. J. et al. | 2014
- S250
-
Utility of CMV PCR in the Evaluation of Allograft Recipients Presenting with DiarrheaSborov, D. W. / Marsh, L. / Yearsley, M. / Geyer, S. / Falk, W. / Devine, S. M. / Hofmeister, C. C. et al. | 2014
- S251
-
Treosulfan-Based Conditioning before Hematopoietic Stem Cell Transplantation: Analysis of Differences Between Children and AdultsStyczynski, J. et al. | 2014
- S252
-
Ex –Vivo T Cell Depleted Allogeneic (TCD) Hematopoietic Stem Cell Transplantation for Advanced Chronic Myelofibrosis: MSKCC ExperienceTamari, R. / Jakubowski, A. A. / Papadopoulos, E. / Sauter, C. / Giralt, S. A. / Castro-Malaspina, H. et al. | 2014
- S253
-
Characteristics and Outcomes of Influenza a Infection in Hematologic Malignancy (HM) Patients and Hematopoietic Stem Cell TransplantVanichanan, J. / Shah, D. P. / Nesher, L. / Ariza-Heredia, E. / Chemaly, R. F. et al. | 2014
- S254
-
Engraftment and Immune Recovery (IR) in Good Risk Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): Comparison of Two Different Approaches Using Cyclophosphamide (CY) for T-Cell TolerizationWagner, J. L. / Grosso, D. / Alpdogan, O. / Carabasi, M. / Filicko, J. / Kasner, M. / Martinez, U. / Weiss, M. / Flomenberg, N. et al. | 2014
- S255
-
Impact of Adenovirus Viremia in Bone Marrow Transplant Patients, 2010-2013Wu, S. / Theodoropoulos, N. / Martin, S. I. / Andritsos, L. A. / Devine, S. M. et al. | 2014
- S258
-
CD137 Expression Identifies Leukemia Specific CTL after in Vitro Priming of Cord Blood T Cells Previously Expanded By CD3/CD28 Co-StimulationAntony, J. / Chen, X. / Szabolcs, P. et al. | 2014
- S259
-
Comparative Analysis of Cell Dose and Viability of Cord Blood Units at Cryopreservation and at Thaw/Infusion for Unrelated Stem Cell Transplantation in Adult RecipientsVasileiou, S. / Baltadakis, I. / Panitsas, F. / Tzannou, I. / Poulopoulou, Z. / Bika, E. / Karatza, M. H. / Papageorgiou, M. / Gigantes, S. / Apostolidis, J. et al. | 2014
- S260
-
Endoscopy Biopsy in Different Sites for the Diagnosis of Lower and Upper Gastrointestinal Graft-Versus-Host DiseaseRodrigues, M. / Costa, E. M. / de Moura Almeida, A. / Alves de Assis, R. / Cardoso Santos, F. N. / Oliveira, E. A. / da Cunha Pasqualin, D. / Bezerra, A. M. / Esteves, I. / Barroso, K. S. et al. | 2014
- S261
-
Autologous Graft Versus Host Disease: An Emerging Complication in Patients with Multiple MyelomaBatra, A. / Cottler-Fox, M. / Harville, T. / Rhodes-Clark, B. S. / Makhoul, I. / Nakagawa, M. et al. | 2014
- S264
-
Chronic Graft Versus Host Disease Presenting As Nephrotic SyndromeDhakal, B. / Cohen, E. P. / Palmer, J. / Hari, P. N. et al. | 2014
- S265
-
Confounding Factors Affecting the National Institutes of Health (NIH) Chronic GVHD Organ-Specific Score and Global SeverityAki, S. Z. / Inamoto, Y. / Storer, B. E. / Carpenter, P. A. / Lee, S. J. / Martin, P. / Flowers, M. E. et al. | 2014
- S266
-
Establishment of Xenogeneic Lung Chronic Graft-Verus-Host Disease Mice ModelFujii, H. / Luo, Z. / Wang, X. / Newbigging, S. / Keating, A. / Egeler, R. M. et al. | 2014
- S267
-
Vitamin D Deficiency Predicts Acute Cutaneous Graft-Versus-Host Disease in Reduced-Intensity Allogeneic Hematopoietic Stem Cell TransplantationGanetsky, A. / Richman, L. P. / Frey, N. V. / Vonderheide, R. H. / Porter, D. L. / Reshef, R. et al. | 2014
- S268
-
Differences Between Gvhd and GVL May be Rather Quantitative and Not Dependent on a Malignant Transformation of the Target CellGramatzki, M. / Guenther, A. / Schub, N. / Kneba, M. / Humpe, A. et al. | 2014
- S269
-
In Silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem Cell Transplant Donor-Recipient PairsJameson-Lee, M. / Koparde, V. N. / Sampson, J. K. / Scalora, A. F. / Khalid, H. / Sheth, N. / Griffith, P. / Serrano, M. G. / Lee, V. / Roberts, C. H. et al. | 2014
- S270
-
CD8-Predominant T Cell Meningitis Accompanies Gvhd in Primates and Is Prevented with ImmunoprophylaxisKaliyaperumal, S. / Sharma, P. / Watkins, B. K. / Furlan, S. N. / Ramakrishnan, S. / Giver, C. / Garcia, A. / Courtney, C. / Hamby, K. / Garrett, A. et al. | 2014
- S272
-
Prevalence of Joint Deficit Among Chronic Gvhd Patients Who Do Not Manifest Cutaneous or Fascial SclerosisKuzmina, Z. / Joe, G. O. / Baird, K. / Cowen, E. W. / Naik, H. B. / Steinberg, S. / Comis, L. / Baruffaldi, J. L. / Avila, D. / Taylor, T. et al. | 2014
- S273
-
Children with Gut Acute Graft Versus Host Disease (aGVHD) Following Allogeneic Stem Cell Transplant (AlloHCT) Have an Increased Incidence of Enteric Bacteria Blood Stream Infections (EB-BSI)Levinson, A. / Pinkney, K. / Jin, Z. / Bhatia, M. / Kung, A. / Foca, M. / Garvin, J. / Satwani, P. et al. | 2014
- S274
-
Early T-Cell Chimerism Is Valuable in Predicting Early Mortality from Steroid-Resistant Acute Graft Versus Host Disease after Myeloablative Allogeneic Haematopoietic Cell TransplantationMinculescu, L. / Madsen, H. O. / Sengelov, H. et al. | 2014
- S275
-
Impact of Conditioning Intensity with or without Total Body Irradiation on Acute Graft-Versus-Host Disease and Clinical OutcomesNakasone, H. / Fukuda, T. / Kanda, J. / Mori, T. / Teshima, T. / Yano, S. / Uchida, N. / Kakihana, K. / Eto, T. / Mori, S. I. et al. | 2014
- S276
-
Monitoring of GRAFT Versus Leukemia Effect with CD34+ Specific DONOR Chimerism AnalysisNorkin, M. / Cogle, C. R. / Leather, H. / Meacham, A. / Rosenau, E. / Moreb, J. S. / Hsu, J. W. / Hiemenz, J. W. / May, W. S. / Wingard, J. R. et al. | 2014
- S277
-
The Impact of Subtherapeutic Tacrolimus Levels on the Incidence of Acute Graft-Versus Host-Disease (aGVHD) in Children Following Allogeneic Hematopoietic Cell Transplantation (AlloHCT) – Redefining the Target RangeOffer, K. / Kolb, M. / Jin, Z. / Bhatia, M. / Kung, A. / George, D. / Garvin, J. / Satwani, P. et al. | 2014
- S278
-
High Day 28 ST2 Biomarker Levels Predict Severe Day 100 Acute Graft-Versus-Host Disease and Day 180 Transplant-Related Mortality after Double-Unit Cord Blood TransplantationPonce, D. M. / Hilden, P. / Mumaw, C. / Devlin, S. / Lubin, M. / Evans, K. / Prockop, S. E. / Scaradavou, A. / Kernan, N. / Giralt, S. A. et al. | 2014
- S279
-
Intensified Mycophenolate Mofetil (MMF) Dosing Is Safe from the Standpoint of Engraftment and Reduces Severe Acute Graft-Versus-Host Disease (aGVHD) after Double-Unit Cord Blood Transplantation (DCBT): An Analysis of 173 PatientsPonce, D. M. / Harnicar, S. / Hilden, P. / Devlin, S. / Evans, K. / Lubin, M. / Kernan, N. / Prockop, S. E. / Scaradavou, A. / Giralt, S. A. et al. | 2014
- S280
-
Missing HLA C Group 1 Ligands in Patients with AML and MDS Is Associated with Reduced Risk of Relapse and Improved Survival after Allogeneic STEM CELL Transplantation (SCT) with Fludarabine and Treosulfan Reduced Toxicity ConditioningShimoni, A. / Bernardi, M. / Yerushalmi, R. / Peccatori, I. / Shem-Tov, N. / Lo Russo, A. / Volchek, Y. / Bonini, M. C. / Nagler, A. / Ciceri, F. et al. | 2014
- S281
-
IL-12hi Rapamycin-Conditioned Dendritic Cells Mediate IFN-γ-Dependent and Fas-Supported Apoptosis of Alloreactive CD4+ T Cells and Inhibit Graft-Versus-Host DiseaseStenger, E. / Rosborough, B. / Mathews, L. / Ma, H. H. / Mapara, M. Y. / Thomson, A. W. / Turnquist, H. et al. | 2014
- S283
-
Cannabidiol – an Innovative Strategy for Graft Versus Host Disease Prevention – an Update of a Phase I/II StudyYeshurun, M. / Shpilberg, O. / Levy-Assaraf, M. / Herscovici, K. / Dreyer, J. / Peck, A. / Israeli, M. / Granot, G. / Gruenewald, T. / Mechoulam, R. et al. | 2014
- S284
-
Silencing of the beta7 Chain Using Antisense Technology to Ameliorate GvhdZilberberg, J. / Fanning, S. / Korngold, R. et al. | 2014
- S286
-
Impact of Bone Marrow Transplant (BMT) Pharmacist (pharma) Interventions on Outcomes in Patients (pts) Undergoing Transplantation at an Academic Medical CenterBednarik, J. / Baron, J. / Katz, D. / Smethers, K. / Ramanathan, M. / Cerny, J. / Fortier, N. / Shanahan, L. / Martin, T. / Petrillo-Deluca, L. et al. | 2014
- S287
-
Administration of Rabbit Anti-Thymocyte Globulin: Slowing Infusion Rate over a 4 Day Course with Aggressive Use of Pre-Medications May Decrease ATG Related Infusion ReactionsClemmons, A. B. / Hartranft, M. E. / Kota, V. / Pantin, J. / Awan, F. T. / Salman, H. / Jillella, A. et al. | 2014
- S288
-
Evaluation of a Data-Derived Algorithm for Preemptive Use of Plerixafor for Stem Cell Harvest in Patients Eligible for Autologous Stem Cell Transplant (ASCT)Danyluk, P. / Gesy, K. et al. | 2014
- S290
-
Effect of Calcineurin Inhibitor Initial Dosing on Drug Levels in Pediatric Stem Cell Transplant RecipientsHente, M. / Langley, R. C. / McNeely, L. R. / Mattingly, S. M. et al. | 2014
- S291
-
Simplified Technique for Administration of High Dose MelphalanHutcherson, D. / Valla, K. / Shah, K. S. / Surati, M. / French, K. / Nooka, A. / Kaufman, J. / Lonial, S. / Cohen, J. B. / Langston, A. et al. | 2014
- S292
-
Evaluation of Revised Vaccination Guideline for Hematopoietic Cell Transplant Patients in Singapore General HospitalLim, Y. J. / Ng, H. Y. / Chong, M. F. / Cheryl Lim, Y. L. / Linn, Y. C. / Loh, Y. / Goh, Y. T. / Hwang, W. Y. / Ho, A. / Krishnan, S. G. et al. | 2014
- S293
-
A Lower Dose of Melphalan (140 mg/m2) As Preparative Regimen for Multiple Myeloma in Patients >65 or with Renal DysfunctionSaunders, I. M. / Gulbis, A. / Champlin, R. E. / Qazilbash, M. H. et al. | 2014
- S294
-
Safety and Efficacy of Plerixafor for Mobilization of Peripheral Blood Stem Cells in Pediatric PatientsTeusink, A. / Pinkard, S. L. / Davies, S. M. / Mueller, M. / Jodele, S. et al. | 2014
- S295
-
Influence of Antifungal Prophylaxis on Cyclophosphosphamide Based Regimen Transplant OutcomesWilliams, D. / Flash, G. et al. | 2014
- S297
-
Information to Coming BMT Patients - Creating a Web SiteBerthelsen, A. M. / Pedersen, L. et al. | 2014
- S298
-
Improving Efficiency of BMT LTFU Clinic, Resulting in Increased Patient SatisfactionCraven, D. / Bumgarner, K. et al. | 2014
- S299
-
Building Capacity for the Future of Hematopoetic Cell Transplant NursingShannon-Dorcy, K. / Ford, R. / Stauffer, D. et al. | 2014
- S300
-
Bridging the Exercise Gap in BMT SurvivorsFlores, E. / Ku, G. / Kozicz, L. / Henning, C. / Printz, C. et al. | 2014
- S301
-
Nursing Workflow is Critical to the Design of a New Pediatric Bone Marrow Transplant UnitHatter, L. / Barnes, D. / Secola, R. et al. | 2014
- S303
-
Sub-Therapeutic Blood Tacrolimus Levels after Conversion from Continuous Intravenous (IV) Infusion to Per Oral (PO) are Associated with Higher Incidence of Acute Graft Versus Host Disease (AGVHD) in Children Following Allogeneic Hematopoietic Cell Transplant (AlloHCT)Kolb, M. / Offer, K. / Jin, Z. / Bhatia, M. / Kung, A. / Satwani, P. et al. | 2014
- S304
-
Simulation: Onboarding Competence with ConfidenceMcLaughlin, C. / Cooper, M. / Sutton, M. et al. | 2014
- S305
-
The synchronization of the nursing process with electronic clinical nursing documentation in Bone Marrow TransplantGrant-Navarro, P. / Wallace, M. / Dowling, M. / Choo, K. / Feustel, J. / Park, Y. S. et al. | 2014
- S306
-
Intravenous Immunoglobulin AdministrationPhillips, R. et al. | 2014
- S307
-
Best Practices Surrounding Urinary Catheters in Bone Marrow Transplant PatientsRensing, K. / Carter, K. et al. | 2014
- S308
-
Finding a Nursing Pipeline…The Professional Nursing AssistantRussell, D. / Lassiter, M. et al. | 2014
- S309
-
Management of Operative Harvest for Bone Marrow DonorsShelton, B. / Pincus, E. / Kane, J. / Zonozy, R. / Meade, J. B. et al. | 2014
- S310
-
Emergency Evacuation of a Bone Marrow Transplant Unit During Superstorm Sandy: This Was Not a DrillThewes, K. / Wuckovich, M. / DeRiso, R. / Blitzstein, S. et al. | 2014
- S311
-
Do we give too much or too little?Vieira, S. / Monroe, D. et al. | 2014
- S312
-
Tranfuse or not to Transfuse?Vieira, S. / Monroe, D. et al. | 2014
- S313
-
Stem Cell Transplant: Is There an App for That?Barnes, Y. / Schmidt, C. / Bernaix, L. et al. | 2014
- S316
-
Author Index| 2014
-
Allogeneic Stem Cell Transplantation for Children with Sickle Cell Disease Achieves Quality of Life Similar to Normal Children and Is Cost EffectiveArnold, S. / Jin, Z. / Weinberg, A. / Bishop, J. / Sands, S. / Licursi, M. / Bhatia, M. / Kung, A. / Satwani, P. et al. | 2014
-
Critical Audit Field Quality InitiativeYoon, C. / Tilearcio, M. C. / Suprunova, J. et al. | 2014
-
Long Term Outcomes of Autologous Hematopoietic Cell Transplant (AHCT) Following Thiotepa-Based High-Dose Therapy (HDT) in Patients with Non-Hodgkin Lymphoma (NHL)Shah, N. A. / Rauenzahn, S. / Wen, S. / Craig, M. / Kanate, A. S. / Hamadani, M. / Cumpston, A. et al. | 2014
-
The Clinical and Financial Cost of Preemptive Management of CMV Disease – Implications for ImmunotherapyJain, N. A. / Ito, S. / Muranski, P. / Lu, K. / Haggerty, J. / Ramos, C. / Cook, L. / Hourigan, C. S. / Childs, R. / Battiwalla, M. et al. | 2014
-
Development of a Unique Anti-AML Immune Therapy Consisting of Cord Blood HSCT and Cord Blood Stem Cell-Derived Dendritic Cell (CB-DC) Vaccinationde Haar, C. / Plantinga, M. / Blokland, N. / Spel, L. / Boes, M. / Nierkens, S. / Boelens, J. J. et al. | 2014
-
Prospective Evaluation of Alternative Donor Availability in 708 Patients: Improved Allograft Access with Enlarging Cord Blood (CB) Inventory for All Patients Including Racial and Ethnic MinoritiesDahi, P. / Ponce, D. M. / Byam, C. / Devlin, S. / Lubin, M. / Evans, K. / Gonzales, A. M. / Sideroff, M. / Wells, D. / Papadopoulos, E. et al. | 2014
-
A Phase 1/2 Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma in the First Salvage Setting: Interim ResultsLaCasce, A. / Sawas, A. / Bociek, R. G. / Ansell, S. / Vose, J. / O'Meara, M. / Advani, R. et al. | 2014
-
Incidence and Mortality of Invasive Fungal Disease in Pediatric Patients after Allogeneic Stem Cell TransplantAftandilian, C. / Agarwal, R. / Kharbanda, S. / Weinberg, K. I. et al. | 2014
-
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Non Malignant Hematologic Disorders (NMHD), Using a Chemotherapy-Only Cytoreductive Regimen and T-Cell Depleted Grafts from Alternative DonorsBoulad, F. / Kernan, N. A. / Prockop, S. E. / Scaradavou, A. / Lehrman, R. / Ruggiero, J. M. / Curran, K. / Kobos, R. / O'Reilly, R. et al. | 2014
-
Reduced-Intensity Conditioning and Umbilical Cord Blood Transplantation in Children. Experience of a Pediatric Hospital in ColombiaEstupinan, M. / Chaparro, M. et al. | 2014
-
Bortezomib Is a Successful Therapeutic Agent for Refractory Autoimmune Cytopenias in Children: A Single Center ExperienceKhandelwal, P. / Davies, S. M. / Marsh, R. A. / Myers, K. C. / El-Bietar, J. / Chandra, S. / Mehta, P. A. / Jodele, S. / Kumar, A. / Bleesing, J. et al. | 2014
-
Nephrotoxicity of Co-Administration of Tacrolimus and Teicoplanin in Allogeneic Hematopoietic Stem Cell Transplant RecipientsMori, T. / Shimizu, T. / Kato, J. / Kohashi, S. / Koda, Y. / Saburi, M. / Okamoto, S. et al. | 2014
-
Palifermin Use in Lymphoma Patients Undergoing Autologous BEAM TransplantsSteinberg, A. / Hayek, C. / Toal, M. / Ursol, E. / Galitzeck, Z. / Malone, A. K. / Osman, K. / Scigliano, E. / Isola, L. et al. | 2014
-
Factors Influencing Tolerance to Total Body Irradiation (400 cGy) for Hematopoietic Stem Cell TransplantationMewawalla, P. / Guerrieri, P. / Jani, P. / Sahovic, E. A. / Lister, J. et al. | 2014
-
Outcomes after Allogeneic Stem Cell Transplantation in Adults for Histiocytic Disorders Including Hemophagocytic LymphohistiocytosisNikiforow, S. / Korman, S. / Eapen, M. / Antin, J. H. et al. | 2014
-
Allogeneic Hematopoietic Stem Cell Transplantation (aHSCT) In Adult Patients With Acute Lymphoblastic Leukemia (ALL): Experience Of The Hematology-Oncology Department At Pontificia Universidad Católica De Chile Between 1994 and 2013Ramirez, P. A. / Ernst, D. / Bertin, P. / Nervi, B. / Jara, V. / Ocqueteau, M. / Sarmiento, M. / Escobar, K. et al. | 2014
-
Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant in Patients with End Stage Renal Disease Requiring Dialysis – a Single Institution ExperienceShadman, M. / Sandmaier, B. M. / Maloney, D. G. / Pagel, J. M. / Hingorani, S. et al. | 2014
-
Rarity of Donor-Derived Malignancy after Allogeneic BMT with High-Dose Post-Transplantation CyclophosphamideSymons, H. J. / Mogri, H. / Kanakry, J. A. / Ambinder, R. / Luznik, L. / Fuchs, E. J. / Jones, R. J. / Kasamon, Y. L. et al. | 2014
-
Complement Component C3 Mediates Th1/Th17 Polarization in Human T Cell Activation and Cutaneous Graft-Versus-Host DiseaseMa, Q. / Li, D. / Alousi, A. M. / Champlin, R. E. / Sale, G. E. / Afshar-Kharghan, V. et al. | 2014
-
Association Between Tacrolimus Levels and Outcomes after Allogeneic Hematopoietic Stem Cell TransplantationCarracedo, C. / Wiggins, L. / Richards, A. et al. | 2014
-
Assessment of Nausea and Vomiting Control with Aprepitant in High-Dose Melphalan Stem Cell TransplantationJohnston, J. / Gregory, K. / Chung, H. et al. | 2014
-
Delirium Management: A Bone Marrow Transplant Veteran Case StudyMadden, W. / Dockery, J. / Larsen, K. / Oldham, D. / Howell, S. et al. | 2014
-
There's nothing mini about a haplo: Nonmyeloablative haploidentical stem cell transplant and the older adultPorter, R. / Lassiter, M. / Russell, D. et al. | 2014
-
Editorial Board| 2014
-
Prospective PCR Monitoring Reveals Adenovirus (ADV) Viremia Is Associated with a Significant Risk of Adv Disease in T-Cell Depleted and Cord Blood Allograft RecipientsHuang, Y. T. / Lee, Y. J. / Kolitsopoulos, Y. / Foldi, J. / Seo, S. K. / Giralt, S. A. / Barker, J. N. / Jakubowski, A. A. / Papanicolaou, G. et al. | 2014
-
Who Is the Best Haematopoietic Stem Cell Donor for a Male Patient with Acute Leukaemia?Ringden, O. / Labopin, M. / Solders, M. / Beelen, D. W. / Arnold, R. / Ehninger, G. / Milpied, N. / Niederwieser, D. / Hamladji, R. M. / Ganser, A. et al. | 2014
-
Accurate Data Entering a Difficult TaskRoepstorff, C. / Petersen, H. / Larsen, H. et al. | 2014
-
The Impact of HLA-Mismatch Direction on the Outcome of Unrelated Bone Marrow Transplantation: A Retrospective Analysis from the JSHCT HLA Working GroupKanda, J. / Maeda, Y. / Ohashi, K. / Fukuda, T. / Miyamura, K. / Mori, S. I. / Morishima, Y. / Atsuta, Y. / Kanda, Y. et al. | 2014
-
A Comparison Between Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Thalassemia MajorGhavamzadeh, A. / Hamidieh, A. A. / Alimoghaddam, K. / Jahani, M. / Mousavi, S. A. / Bahar, B. / Vaezi, M. / Aliabadi, L. S. / Jalali, A. / Jalili, M. et al. | 2014
-
Pegylated Filgrastim Is Comparable with Filgrastim As Support for Autologous Hematopoietic Stem Cell TransplantationHerrera, J. M. / Huertas, J. F. / Saavedra, M. A. / Gomez, R. / Guerrero, A. J. / Duque, J. E. / Urrego, O. M. / Del Pilar Salcedo, R. / Martinez, A. et al. | 2014
-
Characterizing Melphalan Efficacy and Toxicity in Multiple Myeloma Patients with Renal InsufficiencyPatel, S. / Culos, K. / Sweiss, K. / Paul, S. / Patel, P. R. / Rondelli, D. et al. | 2014
-
Cellular Therapeutics Freezer Storage Space Limited By Documentation IssuesSpradley, J. / Rode, C. / Blunk, B. / Birdsey, K. et al. | 2014
-
KIR Haplotype Assigment By Next Generation SequencingGendzekhadze, K. / Cao, L. F. / Nelson, W. / Oki, A. / Geraghty, D. / Senitzer, D. et al. | 2014
-
Phenotypic and Functional Characteristics of NK Cells Associated with Cytomegalovirus (CMV) Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)Nakamura, R. / Franck, A. / Gallez-hawkins, G. / Jeannet, L. / Li, X. / Forman, S. J. / Zaia, J. A. et al. | 2014
-
Hospitalizations Among Adult Survivors of Childhood Cancer Treated with Stem-Cell TransplantationSchechter, T. / Nathan, P. C. / Gassas, A. / Ali, M. / Agha, M. / Greenberg, M. L. / Pole, J. D. et al. | 2014
-
BMT Boot CampWalters, K. / Coleman, P. / Flesch, L. et al. | 2014
-
Results of Hematopoietic STEM CELL Transplantation for Primary Immunodeficiencies in Children in Mexico: A Multicentric ReportMarinez del Campo-Navarro, R. M. / Perez-Garcia, M. / Gonzalez-Ramella, O. / Campos-Gutierrez, M. / Aguilar-Escobedo, D. / Orozco-Alvarado, A. L. / Gonzalez-Llano, O. / Mancias-Guerra, C. / del Campo-Martinez, M. d. / Montero-Ponce, I. et al. | 2014
-
Repeated Dosing of Autologous Cord Blood Is Safe and Feasible in Babies with Congenital HydrocephalusSun, J. / Allison, J. / McLaughlin, C. / Fitzgerald, R. A. / Waters-Pick, B. / Kurtzberg, J. et al. | 2014
-
Squamous Cell Cancers of Head and Neck in Survivors of Allogenic Hematopoietic Stem Cell TransplantationChaulagain, C. / Sprague, K. A. / Klein, A. / Pilichowska, M. / Kaul, E. / Miller, K. B. et al. | 2014
-
Development of Conditioning Regimens Based on HSC-Targeted Antibody ACK2Dinauer, M. / Ngwube, A. / Pech, N. / Xue, X. / Breese, E. / Yoder, M. et al. | 2014
-
Successful Treatment of Post-Transplant Immune Thrombocytopenia with Romiplostim in a Pediatric Patient with X-Linked Chronic Granulomatous DiseaseBuchbinder, D. / Hsieh, L. / Krance, R. A. / Nugent, D. J. et al. | 2014
-
The Role of Occupational Therapy and Its Impact on Quality of Life for the Pediatric Stem Cell RecipientPratt, A. N. / Bakker, J. M. et al. | 2014
-
Celiac Disease Transmitted By Unrelated Cord Blood Stem Cell Transplantation (CBST)Baothman, A. et al. | 2014
-
The Clinical Significance of Human Herpes Virus 6 (HHV-6) Dnaemia in 68 Hematopoietic Cell Transplant Recipients (HSCT)El Zakhem, A. / Shah, D. P. / Mori, N. / Nesher, L. / Ariza-Heredia, E. / Mulanovich, V. E. / Kebriaei, P. / Hosing, C. / Rondon, G. / Chemaly, R. F. et al. | 2014
-
Impact of Granulocyte Transfusion in Patients Submitted Allogeneic Hematopoietic Progenitor Cell Transplantation – a Single Center Experience in BrazilMoreira Funke, V. A. / Melo, A. / Kloppel, D. / Bitencourt, M. / Nabhan, S. / Setubal, D. C. / Sola, C. / Oliveira, M. M. / Farias, J. / Baldanzi, G. et al. | 2014
-
Elevated Expression of Interferon-Induced Genes and Damage Associated Molecular Pattern Receptor Genes in Chronic Graft Versus Host DiseaseHakim, F. / Jin, P. / Memon, S. / Yan, X. Y. / Imanguli, M. / Baird, K. / Cowen, E. W. / Stroncek, D. F. / Gress, R. / Pavletic, S. Z. et al. | 2014
-
Pretransplant Immunosuppression Followed By Reduced Toxicity Conditioning and Stem Cell Transplantation in High Risk ThalassemiaHongeng, S. / Pakakasama, S. / Anurathapan, U. / Andersson, B. S. et al. | 2014
-
Use of Leflunomide in the Treatment of Recalcitrant CMV Infection in Immunocompromised PatientsMori, N. / Vanichanan, J. / Tverdek, F. / Tayar, J. / Ariza-Heredia, E. / Mulanovich, V. E. / Chemaly, R. F. et al. | 2014
-
Chronic Graft Vs. Host Disease Involving Oral Mucous Membranes May Improve with Correction of Vitamin C DeficiencyKletzel, M. / Powers, K. / Hayes, M. et al. | 2014
-
A Quality Improvement Program: Structured Exercise for the Outpatient Blood and Marrow Transplant PatientRoth, S. / Frith, J. / Lassiter, M. et al. | 2014
-
Hematopoietic Cell Transplantation in Patients with Systolic Heart Failure: Can It be Done?Hurley, P. J. / Blaes, A. / Cao, Q. / Konety, S. / Weisdorf, D. et al. | 2014
-
Delay in Onset of First Transfusion and Increased Risk of Graft Rejection in β Thalassemia Patients Undergoing a HLA Matched Related Allogeneic Stem Cell TransplantMathews, V. / Ganapule, A. / Lakshmi, K. / George, B. / Abraham, A. / Viswabandya, A. / Srivastava, A. et al. | 2014
-
Idiopathic Pneumonia Syndrome after HCT: Evidence of Occult Infectious EtiologiesSeo, S. / Renaud, C. / Kuypers, J. M. / Huang, M. L. / Xie, H. / Fisher, C. E. / Hackman, R. C. / Myerson, D. / Kim, Y. J. / Fukuda, T. et al. | 2014
-
A Comparative Study of the Outcome of Isolated Chromosome 13q and Clonal Progression Detected By I-FISH Do Additional Cytogenetic Abnormalities Impact Survival in Multiple MyelomaPeres, E. / Farhan, S. / Janakiraman, S. M. / Kuriakose, P. / Michalowski, S. / Janakiraman, N. et al. | 2014
-
A New Class of Antigen T-Cells That Redirect Bystander T-Cells to CD19 Positive MalignanciesVelasquez, M. P. / Iwahori, K. / Kakarla, S. / Arber, C. / Rodriguez-Cruz, T. / Gerken, C. / Song, X. T. / Gottschalk, S. et al. | 2014
-
Safety of Outpatient Autologous Hematopoietic Cell Transplantation (AuHCT) for Multiple Myeloma and LymphomaKroll, T. M. / Singavi, A. / Schmidt, W. / Eastwood, D. / Drobyski, W. / Horowitz, M. M. / Palmer, J. / Pasquini, M. C. / Rizzo, J. D. / Saber, W. et al. | 2014
-
Experiences with Design and Implementation of a Match Related Donor Satisfaction SurveyKing, B. / Albert, C. / Caloggero, S. / Powers, P. / Coles, P. / Jacobsen, E. et al. | 2014
-
Outcomes of Double Unit Umbilical Cord Blood Transplantation Using Fludarabine/Busulfan Based Reduced Intensity Conditioning RegimenVolodin, L. / Beitinjaneh, A. / Salman, H. / Laughlin, M. J. / Smolkin, M. / Spencer, H. E. / Lee, C. G. / Williams, P. G. / DeGregory, K. / Kindwall-Keller, T. L. et al. | 2014
-
Retrospective Assessment of the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Hemotopoietic Stem Cell Transplantation (HCT) RecipientsBarkley, G. / Spencer, H. E. / Rexrode, D. O. / Beitinjaneh, A. / Volodin, L. / Petroni, G. / Kindwall-Keller, T. L. et al. | 2014
-
Factors Associated with Fatigue in Chronic Graft-Versus-Host DiseaseIm, A. / Mitchell, S. / Steinberg, S. / Curtis, L. / Berger, A. / Baird, K. / Kuzmina, Z. / Zhang, D. / Cole, K. / Avila, D. et al. | 2014
-
Superior Survival Rate Following Conditioning with Etoposide in Childhood ALLIfversen, M. / Winiarski, J. / Saarinen-Pihkala, U. / Mellgren, K. / Glomstein, A. / Arvidson, J. / Lähtenmaaki, P. / Toporski, J. / Rosthoej, S. / Heyman, M. et al. | 2014
-
Plerixafor: A Magic Drug for Urgent PBSC Mobilization from an Adolescent Donor after Failed Bone Marrow HarvestRamzan, M. / Katewa, S. / Chopra, Y. / Sharma, R. / Yadav, S. P. et al. | 2014
-
Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed By Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid LeukemiaZahler, S. / Roy, S. / Ricci, A. / Morris, E. / Harrison, L. / van de Ven, C. / Foley, S. / Cooney-Qualter, E. / Baxter-Lowe, L. A. / Militano, O. et al. | 2014
-
Transplant- Associated Thrombotic Microangiopathy in a Beta-Thalassemia Major Patient Following Bone Marrow Transplant- Case ReportAbusin, G. / Ogu, U. / El-Sheikh, A. A. / Rumelhart, S. / Zepeda-Orozco, D. / Abu-Arja, R. / Nester, C. et al. | 2014
-
Transplant Center Survey of CIBMTR Internal AssessmentsMinas, N. M. / Ruehle, K. et al. | 2014
-
Improvement of Blood Glucose Control on the Bone Marrow Transplant (BMT) Unit: A Retrospective Review of Our Quality Improvement Pilot ProgramShah, G. L. / Rosenberg, A. / Kaul, E. / Stevenson, R. / Chin, J. / Shah, U. / Dinitz, A. / Cossor, F. / Smith, H. / Klein, A. et al. | 2014
-
Non-Myeloablative (NMA) Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of Patients with Hematologic Malignancies Using Busulfan, Fludarabine and Total Body Irradiation (Bu/Flu/TBI) Conditioining: Results of a Phase II TrialBrammer, J. E. / Stentz, A. / Dibb, J. / Frires, R. / Meyers, G. / Curtin, P. / Kovacsovics, T. / Leis, J. / Gajewski, J. / Maziarz, R. T. et al. | 2014
-
Results of Haploidentical Allogeneic Haematopoietic Stem-Cell Transplantation in Patients with Acute Leukaemia: A Single Centre ExperienceGulbas, Z. / Ozkan, H. A. / Ozer, U. G. / Bal, C. et al. | 2014
-
Fludarabine, Intravenous Busulfan, and Total Body Irradiation (FluBuTBI) Conditioning for Allogeneic Peripheral Blood Stem Cell Transplantation the Western Pennsylvania Cancer Institute ExperienceKefela, A. / Sahovic, E. / De Yao, J. / Sadashiv, S. / Rossetti, J. / Fazal, S. / Khan, C. / Berteotti, G. / Lister, J. et al. | 2014
-
Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Significantly Mediate Rituximab Sensitive and Resistant Burkitt Lymphoma (BL) Regression and Improve Survival in Human BL Xenografted NSG MiceChu, Y. / Yahr, A. / Ayello, J. / van de Ven, C. / Barth, M. / Czuczman, M. / Cairo, M. S. et al. | 2014
-
Clinical Features of Cutaneous Pre-Engraftment Syndrome in Patients Receiving Umbilical Cord Blood Stem Cell TransplantationChamplain, A. / Frankfurt, O. / West, D. / Gerami, P. / Guitart, J. / Mehta, J. / Cotliar, J. et al. | 2014
-
An Evaluation of a Pharmacokinetic Interaction Between Tacrolimus and Maraviroc in Allogeneic Stem Cell Transplant RecipientsGanetsky, A. / Miano, T. A. / Hughes, M. E. / Porter, D. L. / Reshef, R. et al. | 2014
-
Effectiveness and Toxicity of High-Dose Cyclophosphamide in Obese Versus Non-Obese Patients Receiving Allogeneic Hematopoietic Cell TransplantHunter, M. / Sabo, R. / McCarty, J. M. / Newland, A. et al. | 2014
-
Relationship Between Intravenous Busulfan Pharmacokinetics and Patient Characteristics in Allogeneic Stem Cell TransplantKeisler, M. D. / Simmons, A. E. / Ivanova, A. / Walko, C. M. et al. | 2014
-
Selected Reviews from the 2014 BMT Tandem MeetingsLaport, G. G. / Martin, P. J. et al. | 2014
-
Extended Follow-up of Myeloablative, HLA-Matched Allogeneic BMT with High-Dose, Post-Transplantation Cyclophosphamide (PTCy) As Sole GVHD Prophylaxis: Favorable Outcomes Despite Low Incidence of Chronic GVHDKanakry, C. G. / Tsai, H. L. / Bolaños-Meade, J. / Smith, B. D. / Gojo, I. / Kasamon, Y. L. / Kanakry, J. A. / Zahurak, M. / Fuchs, E. J. / Jones, R. J. et al. | 2014
-
T-Cell Depleted Allogeneic HSCT for Patients with Relapsed, High-Risk Multiple Myeloma Permits Long-Lasting Remissions in the Absence of Graft-Versus-Host Disease and Provides a Platform for Adoptive Immunotherapeutic ApproachesKoehne, G. / Devlin, S. / Landau, H. / Hassoun, H. / Lesokhin, A. M. / Lendvai, N. / Chung, D. J. / Bravo, C. / Giralt, S. A. et al. | 2014
-
Immunoregulatory B Cells Are Enriched within Transitional and IgM Memory B Cell Subsets in Healthy Donors but Are Reduced and Functionally Impaired in Patients with Chronic Graft-Versus-Host DiseaseSarvaria, A. / Khoder, A. / Alsuliman, A. / Chew, C. / Sekine, T. / Cooper, N. / de Lavallade, H. / Muftuoglu, M. / Yvon, E. / Hamdi, A. et al. | 2014
-
Mixed Chimerism and Graft Loss in Pediatric Recipients of an Alemtuzumab-Based Reduced-Intensity Conditioning Regimen for Nonmalignant DiseaseOshrine, B. / Olson, T. / Bunin, N. et al. | 2014
-
Altered Sexuality and Quality of Life in Female Hematopoietic Cell Transplant Recipients in The First Year Following TransplantationTierney, D. K. et al. | 2014
-
Retrospective Comparison of Day +1 Versus Day +7 Initiation of G-CSF in Patients Undergoing Autologous Hematopoietic Stem Cell TransplantationSpengler, S. / Cordell, L. et al. | 2014
-
Impact of CD34+ Cell-Doses Given during Autologous Stem Cell Transplantation on Absolute Lymphocyte Recovery in Multiple Myeloma PatientsFoster, L. H. / Petroni, G. / Williams, P. G. / Volodin, L. / Beitinjaneh, A. / Laughlin, M. J. / Kindwall-Keller, T. L. et al. | 2014
-
Assessment of the Wilms' Tumor Gene (WT1) Expression in High-Risk Neuroblastoma (NB) Patients WHO Underwent Autologous Hematopoietic Stem Cell Transplantation (HSCT)Khan, S. / Olszewski, M. / Kletzel, M. et al. | 2014
-
Optimal Cryopreservation Conditions to Preserve Viability, Proliferation, and Lytic Function ofCobanoglu, Z. E. / Lee, D. A. / Senyukov, V. et al. | 2014
-
A Population Care Management Approach within a Vertically Integrated, Community-Based, MULTI-Center Health Care System Promotes Quality Hematopoietic STEM CELL Transplant Survivorship CareCheng, J. C. / Desposito, S. / Hurst, M. et al. | 2014
-
Matched Pair Comparison of Busulfan/Cyclophosphamide/Etoposide (BuCyE) to Carmustine/Etoposide/Cytarabine/Melphalan (BEAM) Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation (autoHCT) for LymphomaPasquini, M. C. / Le Rademacher, J. / Flowers, C. / Lill, M. / Costa, L. J. / Shore, T. B. / Vaughan, W. / Craig, M. / Freytes, C. O. / Shea, T. C. et al. | 2014
-
Outcome of Tandem Autologous/Allogeneic Hematopoietic Cell Transplantation in High-Risk Non Hodgkin's Lymphoma Patients: Stanford University ExperienceWudhikarn, K. / Lavori, P. / Arai, S. / Johnston, L. / Laport, G. G. / Lowsky, R. / Miklos, D. B. / Shizuru, J. A. / Hoppe, R. T. / Benjamin, J. et al. | 2014
-
Outcome in Pediatric Patients with a History of Fungal Disease Prior to Allogeneic Stem Cell TransplantAftandilian, C. / Agarwal, R. / Kharbanda, S. / Weinberg, K. I. et al. | 2014
-
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Outcomes for Juvenile Myelomonocytic Leukemia (JMML), a 15-Year Single Center ExperienceQuigg, T. C. / McDonald, L. / Luke, J. / Chan, K. W. / Jude, V. H. / Sanders, R. et al. | 2014
-
BMT Physician-Research Coordinator Relationships: Fostering Reciprocal CommunicationSabo, J. D. / Workman, J. / Yurch, M. / Abounader, D. / Baucco, P. / Cross, S. / Rodela, T. / Urbanek, A. / Kalaycio, M. E. et al. | 2014
-
An Online Secure Shared Drive Proves Crucial to Data ManagementSuprunova, J. / Yoon, C. / Tilearcio, M. C. et al. | 2014
-
Immune Profiling to Predict Treatment Response from Extracorporeal Photopheresis in Graft-Versus-Host DiseaseCordes, S. / Warad, D. / Gustafson, M. / Armstrong, A. / Butler, G. / Patnaik, M. / Hogan, W. / Litzow, M. R. / Winters, J. / Gastineau, D. et al. | 2014
-
Clofarabine As a Bridge to Allogeneic Stem Cell Transplant at New York-Presbyterian HospitalThomas, C. M. / Ippoliti, C. / van Besien, K. / Feldman, E. et al. | 2014
-
Implementation of a Robust Intervention to Address Central Line Associated Blood Stream Infection Rates in an Acute Oncology and Stem Cell Patient Population in an Academic SettingDeGennaro, R. et al. | 2014
-
The Lived Experience of an Autologous Hematopoietic Stem Cell Transplantation: a Qualitative StudyDriscoll, J. / Geary, K. et al. | 2014
-
Safety and Clinical Efficacy of Rapidly-Generated Virus-Specific T Cells with Activity Against Adv, EBV, CMV, HHV6 and BK Virus Administered after Allogeneic Hematopoietic Stem Cell TransplantPapadopoulou, A. / Katari, U. L. / Gerdemann, U. / Tzannou, I. / Martinez, C. / Leung, K. / Carrum, G. / Gee, A. P. / Vera, J. F. / Krance, R. A. et al. | 2014
-
Preventing Primate Gvhd Using a Novel Antagonistic Anti-CD28 Antibody Plus Rapamycin: Downregulation of CD8 Proliferation Predicts Gvhd-Free SurvivalWatkins, B. K. / Poirier, N. / Mary, C. / Blancho, G. / Singh, K. / Garrett, A. / Hamby, K. / Deane, T. / Blazar, B. R. / Vanhove, B. et al. | 2014
-
Late Effects in Infants and Young Children Following Umbilical Cord Blood Transplant Using Busulfan-Based, Myeloablative Non-TBI Conditioning RegimensAllewelt, H. B. / Martin, P. L. / Prasad, V. K. / Page, K. / Kurtzberg, J. et al. | 2014
-
Encouraging Leukemia-Free Survival Rates in 72 Pediatric Acute Lymphoblastic Leukemia (ALL) in CR Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Using a TBI-Free Conditioning RegimenHamidieh, A. A. / Behfar, M. / Aliabadi, L. S. / Jalali, A. / Hosseini, A. s. / Ghavamzadeh, A. et al. | 2014
-
Phase I/II Study of Paclitaxel Plus Ifosfamide Followed By High-Dose Paclitaxel, Ifosfamide, and Carboplatin with Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell TumorsFeldman, D. R. / Glezerman, I. / Patil, S. / Van Alstine, L. / Bajorin, D. F. / Fischer, P. / Hughes, A. / Sheinfeld, J. / Bains, M. / Reich, L. et al. | 2014
-
Brincidofovir (CMX001) Is Well Tolerated in Highly Immunocompromised Pediatric PatientsPrasad, V. K. / Grimley, M. / Papanicolaou, G. / Yu, L. C. / Florescu, D. F. / Brundage, T. M. / Mommeja-Marin, H. / Kurtzberg, J. et al. | 2014
-
Human Herpes Virus-6 Viremia is associated with poor clinical outcomes in Children following Allogeneic Hematopoietic Cell Transplantation (AlloHCT)- Statistical Noise or a Real problem?Violago, L. / Rustia, E. / Jin, Z. / Bhatia, M. / Kung, A. et al. | 2014
-
Cytomegalovirus Reactivation Following Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma and Multiple Myeloma, Single Center ExperienceAlrawi, O. / Najjar, R. / Abujazar, H. / Maslamani, Y. / Salam, M. / Hussein, A. / Alzaben, A. / Abdel-Rahman, F. et al. | 2014
-
Evaluation of Oxidative Stress and Genotoxicity Inpatients Undergoing Autologous Hematopoietic Stemm Cell TransplantationDuarte, F. / Santos, T. N. / Gonçalves, R. P. / Kaufman, J. / Ribeiro, R. / Leitao, J. P. / Mazza, D. / Pitombeira, B. et al. | 2014
-
Maximum Tolerated Dose of Lomustine in Combination with Etoposide, Cytarabine and Melphalan in a Short Conditioning Regimen in the Transplantation of Hematopoietic Stem Cells in Patients with LymphomaHallack Neto, A. o. / Santos, K. B. / Atalla, A. / Ruiz, M. / Costa, L. J. et al. | 2014
-
Unrelated Umbilical Cord Blood Transplant for Diamond-Blackfan AnemiaMcFarren, A. / Page, K. / Parikh, S. / Martin, P. L. / Driscoll, T. A. / Kurtzberg, J. / Prasad, V. K. et al. | 2014
-
Physical and Psychological Symptom Burden and Prognostic Understanding during Hospitalization for Hematopoietic Stem Cell TransplantationEl-Jawahri, A. / Traeger, L. / Kuzmuk, K. / Eusebio, J. / Gallagher, E. / VanDusen, H. / Greer, J. / Pirl, W. / Ballen, K. K. / Spitzer, T. R. et al. | 2014
-
Physical Therapy during the Hemopoietic Stem Cell Transplant Process to Improve Quality of LifeGevedon, A. J. / Monfreda, J. K. et al. | 2014
-
The Impact of Mold Infections after Allogeneic TransplantationChuray, T. L. / Justman, H. A. / Skurka, N. L. / Goldstein, S. C. / Pawarode, A. / Magenau, J. / Couriel, D. R. et al. | 2014
-
Hematopoietic Stem Cell Transplantation (HSCT) for Dyskeratosis Congenita(DC): A Review of 12 Patients(pts) Transplanted in Curitiba, BrazilNichele, S. / Ribeiro, L. / Loth, G. / Kuwahara, C. / Sá Araújo, C. E. / Melo Rodrigues, A. L. / Bitencourt, M. / Koliski, A. / Calado, R. / Malvezzi, M. et al. | 2014
-
High CD8 Cell Doses Correlate with Reduced Relapse Risk and Improved Survival after Allogeneic Peripheral Blood Stem-Cell Transplantation with Reduced-Intensity ConditioningReshef, R. / Luger, S. / Loren, A. / Hexner, E. O. / Nasta, S. D. / Frey, N. V. / Stadtmauer, E. A. / Smith, J. / Porter, D. L. et al. | 2014
-
GRAFT-Versus-Host Disease Clinical Profile and Duration of Immunosuppression Among Patients WHO Received Cord Blood STEM CELL Transplant: A Single Center ExperienceMoreira Funke, V. A. / Kloppel, D. / Melo, A. / Ribeiro, L. / Bonfim, C. / Nunes, E. C. / Sola, C. / Setubal, D. C. / Nabhan, S. / Oliveira, M. M. et al. | 2014
-
Ocular Gvhd: Epidemiology, Risk Factors and Impact on Quality of Life-a Chronic Gvhd Consortium StudyJagasia, M. H. / Chai, X. / Pidala, J. / Inamoto, Y. / Arora, M. / Cutler, C. S. / Flowers, M. E. / Johnston, L. / Pavletic, S. Z. / Lee, S. J. et al. | 2014
-
Sclerodermatous Chronic Gvhd in Patients Receiving Tyrosine Kinase Inhibitors after Allogeneic Hematopoeitic Stem Cell TransplantSalhotra, A. / Palmer, J. / Tsai, N. C. / Paris, T. / Parker, P. M. / Forman, S. J. / Nakamura, R. et al. | 2014
-
Fosaprepitant for the Prevention of Nausea and Vomiting in Patients Receiving BEAM or High-Dose Melphalan Conditioning Regimens for Autologous Hematopoietic Stem Cell TransplantationClark, S. M. / Schaack, L. / DeRemer, D. / Kota, V. / Clemmons, A. B. et al. | 2014
-
Rapid Rituximab and Infliximab Infusions in Pediatric HSCT Patients Are Well ToleratedTeusink, A. / Jodele, S. / Myers, K. C. / Davies, S. M. / Wallace, G. et al. | 2014
-
Improving Contact Precautions Compliance on Bone Marrow Transplant ICUMadden, W. / Carisch, K. / Howell, S. / Dockery, J. et al. | 2014
-
Evidence Based Practice: Cryotherapy for Patients Receiving High Dose MelphalanChiffelle, R. / Cabrera-Behler, M. / Yanes del Castillo, C. et al. | 2014
-
Masthead (Purpose and Scope)| 2014
-
Phase II Trial of Busulfan-Based Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed By Reduced Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk LymphomaChen, Y. B. / Li, S. / Del Rio, C. / Driscoll, J. / Sadrzadeh, H. / Abramson, J. S. / Armand, P. / Barnes, J. / Cutler, C. S. / Fisher, D. C. et al. | 2014
-
Sustained Suppression of Involved Free Light Chain Predicts Long Term Outcomes in Multiple Myeloma after Allogeneic Hematopoietic Stem Cell Transplantation: A Multi-Institutional StudyCornell, R. F. / Dogra, S. / Brazauskas, R. / Goodman, S. / Jagasia, M. H. / Kassim, A. A. / McDonagh, K. T. / Savani, B. N. / Hari, P. N. et al. | 2014
-
Voriconazole Vs. Itraconazole for Antifungal Prophylaxis in Patients with GVHD: A Randomized TrialHayashi, Y. / Kanda, Y. / Nakamae, H. / Kanamori, H. / Ohashi, K. / Hidaka, M. / Yano, S. / Hatanaka, K. / Kohno, A. / Moriuchi, Y. et al. | 2014
-
Water Sampling for Legionella: Managing Positive ResultsMurphy, K. L. et al. | 2014
-
Hemophagocytic Syndrome after Cord Blood Transplantation; Possible Implication of Severe Pre-Engraftment Immune ReactionsYamamoto, H. / Takagi, S. / Uchida, N. / Kageyama, K. / Kaji, D. / Wada, S. / Nishida, A. / Ota, H. / Ishiwata, K. / Tsuji, M. et al. | 2014
-
Phase I Trial of Maintenance Sorafenib after Allogeneic HSCT for Patients with FLT3-ITD AMLChen, Y. B. / Li, S. / Lane, A. A. / Del Rio, C. / Connolly, C. / Ballen, K. K. / Cutler, C. S. / Dey, B. R. / Fathi, A. T. / Ho, V. T. et al. | 2014
-
Cytogenetic Evolution of Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell TransplantationKelemen, K. / Slack, J. L. / Khera, N. et al. | 2014
-
Synergistic Cytotoxicity of the Multikinase Inhibitor Sorafenib with the DNA Alkylating Agent Busulfan, and Nucleoside Analogs in Human FLT3-ITD-Positive Acute Myeloid Leukemia Cell LinesSong, G. / Valdez, B. C. / Li, Y. / Liu, Y. / Champlin, R. E. / Andersson, B. S. et al. | 2014
-
Synergistic Cytotoxicity of Gemcitabine, Clofarabine and Edelfosine (± DNA alkylating agent) in Lymphoma Cell LinesValdez, B. C. / Zander, A. / Song, G. / Murray, D. / Nieto, Y. / Li, Y. / Champlin, R. E. / Andersson, B. S. et al. | 2014
-
Capillary Leak Syndrome in the Pediatric Population: Incidence, Risk Factors and Prognostic ValueLucchini, G. / Daniels, J. / Sörensen, J. / Jarisch, A. / Rettinger, E. / Willasch, A. / Klingebiel, T. E. / Bader, P. et al. | 2014
-
Double Umbilical Cord Blood Transplantation after Novel Myeloablative Conditioning Using FluBu4/TLIAbedin, S. / Peres, E. / Levine, J. / Yanik, G. / Pawarode, A. / Choi, S. W. / Couriel, D. R. et al. | 2014
-
Impact of Invasive Fungal Infections on Mortality, Length of Hospital Stay, and Costs in Allogeneic Hematopoietic Stem Cell Transplant PatientsCai, J. / Prehn, A. / Schlamm, H. / Mucci, M. / Ferraro, A. et al. | 2014
-
Phenytoin Versus Levetiracetam for Busulfan-Induced Seizure Prophylaxis and Hematopoietic Stem Cell Transplantation OutcomesFarhan, S. / Neme, K. / Mikulandric, N. / Pelland, D. / Wautelet, S. / Szymanski, S. / Ruemenapp, K. / Trapp, M. A. / Peres, E. / Janakiraman, N. et al. | 2014
-
Comparison of Peripheral Blood Vs. Bone Marrow Chimerism after a Reduced Intensity Conditioning Allogeneic Stem Cell TransplantKeiffer, G. M. / Gaballa, S. / Palmisiano, N. D. / Shah, G. L. / Grosso, R. / Rudolph, S. / Rosado, S. / Carabasi, M. / Alpdogan, O. / Wagner, J. L. et al. | 2014
-
Favorable Outcomes from Allogeneic Hematopoietic Cell Transplantation in Thailand for Thalassemias and HemoglobinopathiesVanichsetakul, P. et al. | 2014
-
Close Monitoring of Cyclosporine A Concentration as a Means of Preventing Acute Graft-Versus-Host Disease in Allogeneic Stem Cell RecipientsNygaard, M. / Hovgaard, D. / Schjødt, I. / Smedegaard, N. / Vindeløv, L. / Sengeløv, H. et al. | 2014
-
Plerixafor Mobilization in MM Patients and Impact on CD34 Cell Collection and Transplant OutcomesMcBride, A. / Geyer, S. / Jaglowski, S. / Devine, S. M. / Andritsos, L. A. et al. | 2014
-
Empowered Bedside Bone Marrow Transplant Nurses: The Key to Patient SatisfactionMadden, W. / Dockery, J. / Larsen, K. / Oldham, D. et al. | 2014
-
Effective Use of Tociluzimab, an Anti-Interleukin 6 Agent for the Treatment of Steroid-Refractory Grade IV Intestinal Acute Graft-Versus-Host Disease in a Child with Sickle Cell DiseaseKolb, M. / Madina, G. G. / Bhatia, M. / Satwani, P. et al. | 2014
-
Moving a Bone Marrow Transplant Unit Towards a High Reliability UnitMott, B. / Horgan, K. / Flesch, L. / Hayward, M. / Demmel, K. / Morrison, C. et al. | 2014
-
Making RN Orientation Better: Improving the Bone Marrow Transplant ExperienceSeichter, C. / Chapman, J. / Grove, A. / Johnson, K. / Weig, J. et al. | 2014
-
Risk Factors for Graft Failure and Survival after Reduced Intensity (RIC) Conditioning Allogeneic Hematopoietic Cell Transplantation (HCT) for MyelofibrosisGlotzbecker, B. / Kim, H. T. / Cutler, C. S. / Koreth, J. / Armand, P. / Nikiforow, S. / Antin, J. H. / Soiffer, R. J. / Alyea, E. P. / Ho, V. T. et al. | 2014
-
Inhibition of Cdk2 Inactivates EZH2 and Induces Epigenetic Regulation of Fopx3 Leading to the Generation of CD8+ Treg and Protection from GvHDLi, L. / Patsoukis, N. / Nellore, A. / Boussiotis, V. A. et al. | 2014
-
A ″Non-Fratricidal″ αβ-T Cell Receptor That Targets Survivin Expressed By Hematological MalignanciesArber, C. / Feng, X. / Abhyankar, H. / Heslop, H. E. / Brenner, M. K. / Barth, P. / Dotti, G. / Savoldo, B. et al. | 2014
-
Intrathecal Chemotherapy Post Hematopoietic Cell Transplantation for Prevention of Central Nervous System Relapse in Pediatric Acute LeukemiaMitchell, R. / Shah, N. / Lehrman, R. / Kobos, R. / Scaradavou, A. / Boulad, F. / Kernan, N. / O'Reilly, R. / Prockop, S. E. et al. | 2014
-
Twice-Weekly Brincidofovir (CMX001) Shows Promising Antiviral Activity in Immunocompromised Transplant Recipients with Asymptomatic Adenovirus ViremiaGrimley, M. / Prasad, V. K. / Kurtzberg, J. / Chemaly, R. F. / Brundage, T. M. / Wilson, C. / Mommeja-Marin, H. et al. | 2014
-
Cibmtr Retrospective Analysis Reveals Incidence, Mortality, and Timing of Pneumocystis Jiroveci Pneumonia (PCP) after Hematopoietic Stem Cell Transplantation (HSCT)Williams, K. M. / Agwu, A. G. / Chen, M. / Ahn, K. W. / Szabolcs, P. / Boeckh, M. J. / Auletta, J. J. / Tomblyn, M. R. et al. | 2014
-
A Retrospective Review of Nutritional Status as Reflected by Weight Change in Pediatric Patients Post Allogeneic Matched Family Stem Cell TransplantHaughton, C. / O'Connor, M. / Lehmann, L. et al. | 2014
-
Incidence and Risk Factors for the Development of Idiopathic Pneumonitis Syndrome (IPS) after Autologous Hematopoietic Cell Transplantation (AutoHCT) for Patients with LymphomaChen, Y. B. / Lane, A. A. / Logan, B. R. / Maziarz, R. T. / Zhu, X. / Akpek, G. r. / Lazarus, H. M. / Bredeson, C. N. / Olsson, R. / Saber, W. et al. | 2014
-
Long-Term Outcome of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia Beyond First Complete Remission – a Single Center ExperienceHemmati, P. / Terwey, T. / Vuong, L. / Na, I. K. / le Coutre, P. / Dörken, B. / Arnold, R. et al. | 2014
-
Clinical Profile and Outcome of Patients with Graft Rejection Following Related HLA Matched Allogeneic Stem Cell Transplant for β Thalassemia MajorMathews, V. / Ganapule, A. / George, B. / Lakshmi, K. / Abraham, A. / Viswabandya, A. / Srivastava, A. et al. | 2014
-
Prognostic Value of Charlson Comorbidity Index (CCI) and Hematopoietic Cell Transplantation Specific-Comorbidity Index (HCT-CI) in Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) TransplantPaun, O. / Kindwall-Keller, T. L. / Lazarus, H. M. / Laughlin, M. J. / Kolk, M. / Creger, R. / Salman, H. / Gerson, S. L. / Cooper, B. et al. | 2014
-
Reduced Intensity Fludarabine and Intravenous Busulfan (FB2) for Allogeneic Peripheral Blood Stem Cell TransplantationSadashiv, S. / Sahovic, E. / Tayshetye, P. / De Yao, J. / Kefela, A. / Rossetti, J. / Fazal, S. / Khan, C. / Berteotti, G. / Lister, J. et al. | 2014
-
The Use of Tevagrastim (Biosimilar Filgrastim XMO2) for Hematopoietic Stem Cell Mobilization in HLA Matched Sibling Donors for Allogeneic Stem Cell Transplantation to AML/MDS PatientsDanylesko, I. / Sareli, R. / Bloom-Varda, N. / Yerushalmi, R. / Shem-Tov, N. / Volchek, Y. / Shimoni, A. / Nagler, A. et al. | 2014
-
Alemtuzumab As Therapy for Steroid Refractory Acute Gvhd: Promising Efficacy but Higher Rate of Infectious Complications Based on Observational StudyAlam, N. / Atenafu, E. / Gupta, V. / Kuruvilla, J. / Lipton, J. H. / Messner, H. / Seftel, M. / Kim, D. D. et al. | 2014
-
Epidemiology of Chronic Graft-Versus-Host Disease in the Pediatric Recipients of Hematopoietic Stem Cell TransplantationMahadeo, K. M. / Kapoor, N. / Shah, A. J. / Abdel-Azim, H. / Parkman, R. et al. | 2014
-
PROSE Treatment in Ocular Graft Versus Host Disease; A Five Year Follow-upRidges, R. / Agranat, J. S. / Hatch, M. L. / Jacobs, D. S. et al. | 2014
-
Amyloid Treatment Pearls: Standardizing an Approach to Patient CareFeatherstone, C. / Hylton, H. et al. | 2014
-
Red Bag Review: A Medication Reconciliation InitiativeMosadegh, S. / O'Connor, M. et al. | 2014
-
The Importance of Skill Simulation and Its Role in the Clinical Performance of the New Graduate BMT NurseSito, E. / Russell, D. et al. | 2014
-
Determining the value of weekly surveillance blood cultures as a screening tool for occult bloodstream infection for post allogeneic hematopoietic stem cell transplant (HSCT) patients on PrednisoneCoffey, G. / Kenny, S. / Jackson, L. / Bhatt, V. et al. | 2014
-
A Pilot Feasibility Study of Hypotensive Hematopoietic Malignancy Patients’ USCOM ReadingsParmentier, M. / Ahrens, T. / Dalske, R. / Klinkenberg, W. D. / Potter, P. / Uy, G. et al. | 2014
-
Officers and Directors of ASBMT| 2014
-
Clinical Responses in Patients Infused with T Lymphocytes Redirected to Target Kappa-Light Immunoglobulin ChainRamos, C. A. / Savoldo, B. / Liu, E. / Gee, A. P. / Mei, Z. / Grilley, B. / Rooney, C. M. / Heslop, H. E. / Brenner, M. K. / Dotti, G. et al. | 2014
-
Plasma and Intracellular Population Pharmacokinetic Analysis of Fludarabine in Pediatric Allogeneic Hematopoietic Cell Transplant (alloHCT) RecipientsLong-Boyle, J. / Sambol, N. / Dvorak, C. C. / Cowan, M. J. / Lee, S. / Huang, L. / Horn, B. / Stricherz, M. / Tolar, J. / Orchard, P. et al. | 2014
-
Chronic Graft Versus Host Disease and Immunosuppression Burden Is Significantly Lower Following Adult Cord Blood Transplantation Versus Matched Unrelated Donor TransplantationGutman, J. A. / Myint, H. / Lee, C. K. / Smith, C. / Nguyen, V. / Pollyea, D. A. et al. | 2014
-
Kinetics of Chimerism and Early Immune Recovery in Patients Receiving Unmodified Peripheral Blood Allogeneic Grafts Followed By Post-HSCT High Dose Cyclophosphamide for Gvhd ProphylaxisPaluri, R. / Lamb, L. / Cloud, G. / Mineishi, S. et al. | 2014
-
Targeting Sag in Donor T Cells As a Novel Strategy for Reducing GvhdMathewson, N. / Toubai, T. / Sun, Y. / Wang, Y. / Oravecz-Wilson, K. / Hou, G. / Wu, J. / Reddy, P. et al. | 2014
-
Long-Term Survival and Late Effects Among 1-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation (2nd Allo HCT) for Relapsed Acute Leukemia and Myelodysplastic Syndrome: A Report from the CibmtrDuncan, C. / Majhail, N. S. / Brazauskas, R. / Wang, Z. / Cahn, J. Y. / Kamble, R. T. / Frangoul, H. A. / Hayashi, R. J. / Hsu, J. W. / Jacobsohn, D. A. et al. | 2014
-
Transplant Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia: The Cibmtr ExperienceMehta, P. A. / Eapen, M. / Zhang, M. J. / He, W. / Seber, A. / Kitko, C. L. / Hale, G. A. / Davies, S. M. et al. | 2014
-
Second Autologous Stem Cell Transplant- an Effective Therapy for Relapsed Multiple MyelomaSingh Abbi, K. K. / Devlin, S. / Giralt, S. A. / Landau, H. et al. | 2014
-
Autologous Stem Cell Mobilization with Pegfilgrastim and Planned Plerixafor Is Equally Effective and Safer As Compared with Cyclophosphamide, Pegfilgrastim and PlerixaforTuazon, S. / Sharma, M. / Zhan, T. / Kasner, M. / Alpdogan, O. / Martinez, U. / Grosso, D. / Filicko, J. / Pro, B. / Wagner, J. L. et al. | 2014
-
Can Platelet transfusion be unnecessary?Vieira, S. / Monroe, D. et al. | 2014
-
Housing and Caregiver Challenges for Hematopoietic Cell Transplant Recipients and Their Potential Solutions: Results from a Mixed-Method StudyPreussler, J. M. / Majhail, N. S. / Mau, L. W. / Carr, D. W. / Bevans, M. / Clancy, E. / Messner, C. / Parran, L. / Pederson, K. / Stickney Ferguson, S. et al. | 2014
-
Variation in Inpatient Costs of Hematopoietic Cell Transplantation Among Transplant Centers in the United StatesThao, V. / Golberstein, E. / Thomas, W. / Kozhimannil, K. B. / Mau, L. W. / Preussler, J. M. / Denzen, E. / Majhail, N. S. et al. | 2014
-
Dual-Specificity CAR+ T Cells to Target B-Cell Malignancies and Opportunistic Fungal InfectionKumaresan, P. R. / Manuri, P. R. / Albert, N. D. / Singh, H. / Rabinovich, B. / Krishnamurthy, J. / Maiti, S. N. / Simon, O. / Mi, T. / Lee, D. et al. | 2014
-
Refined/Accelerated T Cell Therapies for the Treatment of EBV+ LymphomasPerna, S. K. / Ngo, M. / Lapteva, N. / Ando, J. / Rollins, L. / Diouf, O. / Leen, A. M. / Vera, J. F. / Torrano, V. / Gee, A. P. et al. | 2014
-
Central Nervous System Leukemia in Acute Myeloid LeukemiaAltriki, M. / Cheng, M. R. / Fauble, V. / Khera, N. / Leis, J. / Mesa, R. A. / Noel, P. / Slack, J. L. / Tibes, R. / Sproat, L. O. et al. | 2014
-
Should We Screen for Food Allergy Post BMT? A Case Report of Allergy to Tree Nuts Transferred after Bone Marrow TransplantationThomas, S. / Schroer, B. / Hanna, R. et al. | 2014
-
Induction of a CD8+ T Cell Response to Tumor Antigens Is Associated with Improved Survival in Patients Transplanted for Acute Myeloid LeukemiaNagra, S. / Goodyear, O. C. / Khan, J. / Jilani, N. Y. / Ferguson, P. / Russell, N. / Dennis, M. / Vyas, P. / Siddique, S. / Craddock, C. et al. | 2014
-
Synergistic Cytotoxic Effect of the PARP Inhibitor ABT888 and Busulfan in Acute Leukemia Cell LinesPatel, P. / Mahmud, D. / Oh, A. / Rondelli, D. et al. | 2014
-
A Multidisciplinary Team Approach for Diagnosis and Treatment of Patients with AL AmyloidosisFinn, K. T. / Fennessey, S. / Shelton, A. C. / Brauneis, D. / Teschner, T. / Quillen, K. / Sloan, J. M. / Renteria, A. S. / Seldin, D. C. / Sanchorawala, V. et al. | 2014
-
Extracorporeal Photopheresis Performed on the CELLEX® Compared with the UVAR-XTS Instrument Is More Efficient and Better Tolerated in Children with Steroid-Refractory GVHDKapadia, E. / Currier, D. / Perez-Albuerne, E. / Wong, E. / Jacobsohn, D. A. et al. | 2014
-
Differential Properties Of Stromal Cells From Bone Marrow, Adipose, Cardiac and LiverMcNiece, I. / Sivajothi, S. et al. | 2014
-
Prophylactic Broad Spectrum Antibiotics at the Onset of Neutropenia in HSCT Do Not Change the Number of Febrile Days or Duration of HospitalizationHaines, H. et al. | 2014
-
Amphotericin B Nasal Spray Appears Effective in Preventing Breakthrough Fungal Infections in Colonized SCT RecipientsTrifilio, S. / Heraty, R. / Zomas, A. / Liu, D. / Zhang, J. / Zhao, C. / Mehta, J. et al. | 2014
-
No-Myeloablative Conditioning Regimen Cyclosphophamide-Fludarabine-ATG (Cy-Flu-ATG) Results in Better Overall Survival Compared with Myeloablative Doses of Cy with or without ATG, in High-Risk Bone Marrow Failure Syndromes (BMFS) PatientsAbello, V. / Villamizar, L. / Pedraza, E. / Esguerra, H. / Rosales, C. / Rosales, M. / Figueroa, J. / Cordoba, I. / Linares, A. et al. | 2014
-
Safety of Stem Cell Mobilization in Donors with Sickle Cell TraitAl-Khabori, M. / Al-Ghafri, F. / Al-Kindi, S. / Al-Riyami, A. Z. / Al-Farsi, K. / Al-Huneini, M. / Dennison, D. / Al-Rawas, A. / Daar, S. et al. | 2014
-
Myelodysplastic Syndrome Patients with Disease Progression after Cytoreductive Therapy Have Poor Survival and High Non-Relapse Mortality after Full-Intensity Allogeneic Hematopoietic Cell TransplantationGerds, A. T. / Rybicki, L. / Hamilton, B. K. / Sobecks, R. / Duong, H. / Andresen, S. / Hanna, R. / Corbett, E. / Starn, J. / Bolwell, B. et al. | 2014
-
Post-Transplant Isoagglutinin Induced Pure Red Cell Aplasia; Incidence and Clinic OutcomesKochuparambil, S. / Litzow, M. R. / Hogan, W. / Hashmi, S. / Gastineau, D. / Patnaik, M. et al. | 2014
-
Hematopoietic Cell Transplant Co-Morbidity Index (HCT-CI): Ability to Predict Outcomes in Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)Palmisiano, N. D. / Gaballa, S. / Alpdogan, O. / Carabasi, M. / Filicko, J. / Kasner, M. / Martinez, U. / Wagner, J. L. / Weiss, M. / Flomenberg, N. et al. | 2014
-
Prospective Validation of a Busulfan Pharmacokinetic Model in Children: Therapeutic Drug Monitoring Remains of Utmost Importance to Optimize Outcomes of HCTvan Reij, E. / van Maarseveen, E. / Bartelink, I. / Rademaker, C. / Egberts, T. / Boelens, J. J. et al. | 2014
-
Factors Affecting the Incidence of Severe (Stage 2-4) Gastrointestinal (GI) Graft-Versus-Host Disease (GVHD) in Adult Patients (pts) Undergoing Allogeneic Hematopoietic Transplant (Allo-HCT) for Hematologic MalignancyBetcher, J. / Chang, Y. H. / Noel, P. / Leis, J. / Sproat, L. O. / Fauble, V. / Khera, N. / Adams, R. / Slack, J. L. et al. | 2014
-
Improved Overall Survival in Patients with Grade III and IV Acute Graft-Versus-Host DiseaseEl-Jawahri, A. / Li, S. / Coughlin, E. / Ho, V. T. / Alyea, E. P. / Armand, P. / Ballen, K. K. / Dey, B. R. / Glotzbecker, B. / Koreth, J. et al. | 2014
-
Implementation of Parameter Transfusion Orders for Stem Cell Transplant Recipients Results in Increased Nursing Autonomy, Decreased Transfusion Delays, and Improved Patient CareSchneider, V. F. / Kim, S. / Christensen, A. / Szewczyk, N. / Dela Cruz, B. P. / Kresta, K. / Tewari, P. et al. | 2014
-
Implementation of a Standardized Cardiac Monitor Care Process to Reduce Nuisance AlarmsColeman, K. / Flesch, L. / Hayward, M. / Koons, C. / McKenna, L. A. / Dandoy, C. et al. | 2014
-
Does Plerixafor do the trick in mobilising Stem Cells?Vieira, S. / Monroe, D. et al. | 2014
-
Effect of Antithymocyte Globulin Source on Outcomes of Bone Marrow Transplantation for Severe Aplastic AnemiaAntin, J. H. / Deeg, H. J. / Korman, S. / Bonfim, C. / Nakamura, R. / Horowitz, M. M. / Weisdorf, D. / Eapen, M. / Pulsipher, M. A. et al. | 2014
-
CMV-Specific T-Cell Therapy Improves Immune Reconstitution Following Unrelated Donor HSCT: Results of a Randomized Controlled TrialChen, F. / Peniket, A. / Tholouli, E. / Bloor, A. / Chakraverty, R. / Marks, D. / Pagliuca, A. / Russell, N. / Thomson, K. / Beard, H. et al. | 2014
-
Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation For Relapsed/Refractory Hodgkin Lymphoma In The Brentuximab Vedotin EraAnderlini, P. / Saliba, R. / Ledesma, C. / Chancoco, C. M. / Alexander, T. R. / Alousi, A. M. / Hosing, C. / Khouri, I. F. / Nieto, Y. / Popat, U. R. et al. | 2014
-
Durable Engraftment, Correction of Genetic Defects and Prevention of Veno-Occlussive Disease, Following Blood and Marrow Transplantation with an HLA-Matched Sibling DONOR, Using a Reduced Toxicity Conditioning Regimen with Busulfan, Reduced Dose CyclophosMahadeo, K. M. / Agarwal, R. / Weinberg, K. I. / Abdel-Azim, H. / Miklos, D. B. / Shah, A. J. / Tabba, L. / Kapoor, N. et al. | 2014
-
Sequential Myeloablative Autologous Stem Cell Transplantation and Reduced Intensity Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor Risk Refractory or Recurrent Hodgkin (HL) and Non-Hodgkin Lymphoma (NHL)Satwani, P. / Jin, Z. / Bhatia, M. / Garvin, J. / George, D. / Chaudhury, S. / Talano, J. A. / Sosna, J. / Morris, E. / Harrison, L. et al. | 2014
-
Practices and Experiences of Nurses Working on a Pediatric Bone Marrow Transplant UnitMorrison, C. / Morris, E. et al. | 2014
-
Hear Our Voices: Patient's Perspective of Financial Impact of Allogeneic HCTWeise, M. / Khera, N. / Noel, P. et al. | 2014
-
Autologous Peripheral Blood Stem Cell Transplant Using BEAM or CBV without Cryopreservation. 82 Procedures in Patients with Relapsed Hodgkin and Non- Hodgkinxs LymphomaKarduss, A. / Perez, R. / Gomez, R. / Jimenez, A. / Reyes, P. / Deossa, H. / Hurtado, L. et al. | 2014
-
High-Resolution Donor-Recipient HLA Matching Does Not Influence Acute or Chronic Gvhd in Umbilical Cord Blood TransplantationLazaryan, A. / Wagner, J. E. / Brunstein, C. G. / Defor, T. / MacMillan, M. L. / Blazar, B. R. / Weisdorf, D. J. / Arora, M. et al. | 2014
-
Allogeneic Hematopoietic Cell Transplantation Using Fludarabine, Melphalan and Bortezomib (Flu/Mel/Vel) Conditioning for Consolidation of VGPR or CR in MyelomaNishihori, T. / Ochoa-Bayona, J. L. / Sullivan, D. / Baz, R. / Shain, K. / Hillgruber, R. / Anasetti, C. / Alsina, M. et al. | 2014
-
Acute Graft Versus Host Disease Following Sibling Donor Transplantation for Thalassemia MajorGeorge, B. / Pn, N. / Mathews, V. / Lakshmi, K. / Viswabandya, A. / Abraham, A. / Ganapule, A. / Srivastava, A. et al. | 2014
-
Busulfan, Melphalan, and Thiotepa Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) of Pediatric Patients with Acute Leukemia and Central Nervous System (CNS) DiseaseForlenza, C. J. / Kobos, R. / Kernan, N. A. / Scaradavou, A. / Prockop, S. E. / Curran, K. / Shukla, N. / Steinherz, P. G. / O'Reilly, R. / Boulad, F. et al. | 2014
-
Neck Tenderness As an Initial Presentation of Disseminated Aspergillosis; FNA Is an Option or a Must?Badawy, S. et al. | 2014
-
Follow-up of Vaccination Status in Adults after Allogeneic Hematopoietic Stem Cell TransplantationBauters, T. / Dinh, L. / De Munter, J. / Quaghebeur, M. / Mazure, D. / Noens, L. / Kerre, T. et al. | 2014
-
Prospective Multicenter Phase II Study of Myeloablative Conditioning Consisted of Intravenous Busulfan and Fludarabine +/- Total Body Irradiation for Older Patients (55 years and older): Final Analysis of the JSCT FB09 StudyUchida, N. / Hidaka, M. / Sakura, T. / Miyamoto, T. / Fujisaki, T. / Eto, T. / Maeda, Y. / Fukuno, K. / Matsumoto, K. / Morita, K. et al. | 2014
-
Previous Infections in the Allogenic Hematopoietic Stem Cell Transplant Receiver, As a Risk Factor for the Development of Acute Graft Versus Host DiseaseOlaya, A. / Castorena, I. / Pérez, M. / Lopez, G. / Del Campo, A. / Gaytan, F. et al. | 2014
-
Using Lymphocyte Phenotypes to Predict Successful Responses to Extracorporal Photopheresis (ECP) in Patients Suffering from Chronic GvHDDalal, J. / Yankee, T. / Hassaballa, A. / Parker, B. / Hirner, A. / Bunch, J. / McGuirk, J. / Abhyankar, S. et al. | 2014
-
A Multi-Disciplinary Approach to Reducing Hospital Acquired C. Difficile in the BMT Patient PopulationAurin, C. / Scurria, A. / Krugh, D. / Dickman, J. / Lamprecht, M. / Liscynesky, C. et al. | 2014
-
a Pre, Intra, Post-Transplant Trajectory Approach to Discharge Teaching--Nurse Coordinator Discharge Teaching Competency: Pre-Hematopoietic Cell Transplant Admission.Gorospe, G. / Cooke, L. / Johnson, S. / Bourque, A. / Thomson, B. et al. | 2014
-
Safety and Efficiency of Administering Foscarnet in an Intensive Adult Bone Marrow Transplant Clinic: A Multidisciplinary ApproachKenny, S. / Jackson, L. / Coffey, G. / Eaton, A. A. / Giralt, S. / Barker, J. N. / Harnicar, S. et al. | 2014
-
What is the Difference Between Inpatient BMT Patients Who Fall vs Non-fallers: A Retrospective StudyArring, N. / Shelton, T. et al. | 2014
-
Toward a Better Understanding of Pediatric BMT Adherence: An Exploration of Provider PerceptionsSkeens, M. / Akard, T. F. / Gilmer, M. J. / Garee, A. / Miller, A. et al. | 2014
-
CD4+ Invariant Natural Killer T Cells Protect from Acute Graft-Versus-Host Disease Lethality through a Dramatic Expansion of Donor-Derived CD4+FoxP3+ Regulatory T CellsSchneidawind, D. / Pierini, A. / Alvarez, M. / Pan, Y. / Baker, J. / Kim, B. S. / Nishikii, H. / Büchele, C. / Meyer, E. / Negrin, R. et al. | 2014
-
Infections Are the Major Cause of Non Relapse Mortality (NRM) after T Cell Depleted (TCD) Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Myelodysplastic SyndromeTamari, R. / Devlin, S. / Goldberg, J. D. / Hilden, P. / Jakubowski, A. A. / Papadopoulos, E. / Ponce, D. M. / Sauter, C. / Young, J. / Giralt, S. A. et al. | 2014
-
Clinical Trial Evaluating DC/AML Fusion Cell Vaccination in AML Patients Who Achieve a Chemotherapy-Induced RemissionRosenblatt, J. / Stone, R. M. / Uhl, L. / Neuberg, D. / Vasir, B. / Somaiya, P. / Joyce, R. / Levine, J. D. / Boussiotis, V. A. / Zwicker, J. et al. | 2014
-
Risk Factors for Musculoskeletal Symptoms in 5-20 Year Survivors Who Received Myeloablative Hematopoietic Cell Transplant (HCT)Yi, J. C. / Martin, P. / Storer, B. E. / Abrams, J. R. / Artherholt, S. B. / Ott, S. M. / Flowers, M. E. / Syrjala, K. L. et al. | 2014